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1. ABSTRACT	  	  
	  
Tumor	  microenvironment	  contributes	  strongly	  to	  tumor	  evolution	  toward	  metastasis,	  a	  final	  
stage	   in	   cancer	   progression.	   It	   provides	   essential	   clues	   to	   promote	   migration	   of	   cancer	   cells	   in	  
metastatic	   sites.	   Moreover,	   inflammatory	   cells	   and	   immunomodulatory	   mediators	   present	   in	   the	  
microenvironment	   are	   able	   to	   polarize	   the	   host	   immune	   response,	   thereby	   potentiating	   primary	  
tumor	  development.	  The	  reciprocal	  and	  dynamic	  interactions	  between	  microenvironment	  and	  tumor	  
cells	  orchestrate	  critical	  steps	  of	  evolution	  toward	  metastasis.	  
To	  address	  the	  role	  of	  inflammation	  in	  tumor	  progression,	  a	  mouse	  model	  of	  downregulated	  
inflammation	   was	   used:	   the	   NALP3	   gene	   in	   these	   mice	   is	   knocked-­‐out,	   causing	   an	   impaired	  
processing	   of	   the	   two	   inflammatory	   cytokines	   Interleukin-­‐1β	   and	   IL-­‐18	  which	   are	   essential	   for	   the	  
recruitment	  and	  activation	  of	  immune	  cells.	  In	  this	  case,	  a	  decrease	  in	  tumor	  growth	  and	  metastasis	  
was	  observed	  in	  previous	  studies,	  leading	  us	  to	  investigate	  the	  molecular	  and	  cellular	  interactions	  of	  
tumor	  and	  immune	  cells	  in	  inflammatory	  and	  non-­‐inflammatory	  contexts.	  
Gene	   expression	   analysis	  was	   performed	   on	   two	   types	   of	  mouse	   tumor	   cells:	   the	   B16-­‐F10	  
melanoma	  cells	  seem	  to	  be	  more	  dependent	  on	  the	  immune	  cells	  recruitment	  to	  metastasize	  in	  vivo,	  
while	  the	  Lewis	  Lung	  Carcinomas	  cells	  showed	  a	  quite	  equivalent	  growth	  in	  both	  wild-­‐type	  or	  NALP3	  
knock-­‐out	  mice.	  Different	  techniques	  were	  used	  to	  do	  so,	  such	  as	  standard	  in	  vitro	  assays	  and	  mRNA	  
expression	   analyses,	   and	   in	   vivo	   tests	   with	   extraction	   of	   tumoral	   mRNA	   by	   Laser	   Capture	  
Microdissection.	  Gene	  expression	  analyses	  of	  tumor	  cells	  were	  performed	  to	  address	  the	  influence	  of	  
the	   inflammatory	  background.	  Comparison	  of	  these	  two	  gene	  expression	  profiles	  may	  reveal	  genes	  
related	  to	  the	  specific	  reactive	  inflammatory	  response	  surrounding	  the	  given	  metastases.	  	  
Another	   point	   that	   was	   investigated	   was	   the	   importance	   of	   the	   IL-­‐1R1,	   receptor	   of	  
interleukin-­‐1.	   Since	   it	   represents	   the	   counterpart	   of	   IL-­‐1β	   signaling,	   its	   expression	   by	   immune	   and	  
tumor	   cells	   may	   correlate	   with	   degree	   of	   tumor	   growth	   and	   invasion.	   In	   vitro	   and	   in	   vivo	   assays	  
allowed	   better	   understanding	   the	   importance	   of	   this	   receptor.	   While	   a	   downregulation	   of	   this	  
receptor	  impairs	  proliferation	  of	  in	  vitro	  cell	  cultures,	  at	  the	  in	  vivo	  level,	  the	  number	  of	  metastases	  is	  
decreased	  too.	  	  
These	   results	   provide	   potential	   clues	   indicating	   the	   important	   role	   played	   by	   the	  
inflammatory	  cells,	  and	  how	  they	  can	  support	  and	  promote	  tumor	  progression,	  in	  particular	  through	  
the	  expression	  of	  NALP3.	  The	  adaptation	  mechanisms	  of	  tumor	  cells	  to	  their	  microenvironment	  were	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2.	  INTRODUCTION	  	  
	  
With	  7.6	  million	  deaths	   in	  2008,	   cancer	   is	   a	   leading	   cause	  of	  death	  worldwide,	  with	  a	   vast	  
majority	   of	   cancer-­‐related	   deaths	   caused	   by	   dissemination	   of	   tumor	   cells,	   phenomena	   called	  
metastasis	  [1].	  Furthermore,	  the	  projections	  show	  a	  continued	  rise	  to	  over	  11	  million	  in	  2030.	  	  Being	  
a	  major	  public	  health	  problem,	   it	  has	  never	  been	  more	   important	  to	  find	  new	  solutions	   in	  order	  to	  
eradicate	   this	   complex	   and	   wide	   propagated	   disease.	   The	   crucial	   issue	   is	   thus	   to	   discover	   and	  
develop,	   through	   the	  better	  understanding	  of	   the	  biology	  of	   tumors	  and	  metastases,	  effective	  and	  
novel	  therapies	  to	  treat	  patients.	  	  
The	   main	   difficulty	   resides	   in	   the	   huge	   complexity	   of	   the	   disease,	   enclosing	   such	   a	   lot	   of	  
different	   types	  of	   cancer	   and	  multiple	   genetic	   variations	  between	  all	   of	   them.	  However,	   the	  many	  
different	   steps	   of	   transformation	   could	   also	   be	   seen	   as	   many	   potential	   and	   specific	   therapeutic	  
targets.	   Moreover,	   the	   complex	   interactions	   between	   tumor	   cells	   and	   their	   microenvironment	  
represent	  a	  key	  issue	  to	  determine	  the	  potentiality	  of	  a	  tumor	  to	  evolve	  or	  not	  toward	  metastasis.	  In	  
the	  past	  decades,	  the	  research	  was	  more	  based	  on	  the	  concept	  of	  cancer-­‐cell-­‐	  and	  genome-­‐centered	  
models,	   with	   publications	   mainly	   focused	   on	   describing	   oncogenes	   and	   suppressor	   genes,	   their	  
mutations	   and	   changes	   of	   expression	   in	   tumor	   cells.	   However,	   even	   if	   these	   concepts	   are	  
fundamental	  to	  understand	  how	  the	  tumor	  cells	  acquire	  self-­‐sufficiency	  for	  growth	  and	  proliferation,	  
the	  surrounding	  tissue	  is	  the	  other	  key	  player	  that	  allows	  these	  cells	  to	  remain	  and	  proliferate,	   in	  a	  
given	  tissue	  [2].	  At	  some	  point,	  the	  microenvironment	  is	  likely	  to	  be	  the	  major	  component	  allowing	  
and	  promoting	   tumorigenesis,	   thus	  even	  more	  so	  during	  angiogenesis	  and	  metastasis.	  That	   is	  why,	  
more	   recently,	   the	   scientific	   community	   began	   to	   study	   new	   models	   including	   the	   important	  
component	   that	   the	  microenvironment	   represents.	   Since	   then,	  we	   could	   understand	   that,	   besides	  
the	  genetic	  modifications	  encountered	   in	  the	  tumor	  cells,	   the	  stroma	  is	  also	  subject	  to	  genetic	  and	  
phenotypic	   changes	   during	   cancer	   progression.	   There	   are	   even	   more	   and	   more	   evidences	   that	  
support	  the	  concept	  in	  which	  tumor	  microenvironment	  is	  driven	  to	  undergo	  specific	  modifications	  in	  
contact	   with	   the	   tumor,	   getting	   enslaved,	   and	   that	   in	   the	   end,	   the	   control	   of	   tumor	   cells	   is	   so	  
important	  that	  its	  microenvironment	  reaches	  a	  stage	  of	  promoting	  tumor	  progression	  [3].	  	  
In	  particular,	   infiltrating	  immune	  cells	  play	  decisive	  roles,	  and	  thus	  at	  every	  stages	  of	  tumor	  
growth	   and	   evolution,	   through	   the	   manipulation	   of	   other	   immune	   cells,	   modifying	   immune	  
surveillance.	   Inflammatory	  cells	  and	  their	  mediators	  contribute	  to	  local	   invasion	  but	  also	  to	  general	  
dissemination.	  The	  many	  bidirectional	  and	  dynamic	   interaction	  between	  tumor	  -­‐	  and	   immune	  cells	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Tumor-­‐Host	  Interactions:	  the	  basics	  	  
	   	  
The	  Tumor	  Side	  	  
A	  tumor	   is	  defined	  as	  an	  abnormal	  proliferation	  of	  cells	   in	  a	   tissue,	  also	  called	  a	  neoplasm.	  
This	   is	   caused	   by	   genetic	   mutations	   that	   are	   due	   to	   many	   different	   environmental	   factors	   like	  
radiations,	   pollution	   or	   infections.	   The	   term	   of	   carcinogenesis	   is	   used	   to	   describe	   the	   multistep	  
process	   by	   which	   normal	   cells	   are	   transformed	   into	   cancer	   cells,	   through	   acquisition	   of	   new	  
characteristics.	  	  
Key	  modifications	  due	  to	  accumulation	  of	  
mutations	   (Fig.	   1-­‐A)	   consist	   of	   resistance	   to	  
apoptosis,	  insensitivity	  to	  growth	  signals	  and	  self-­‐
sufficiency	   in	   growth	   signals.	   Subsequently,	  
changes	   at	   cellular	   and	   genetic	   level	   reprogram	  
the	  cell	  so	  that	  cellular	  division	  gets	  uncontrolled.	  
Therefore	   a	   malignant	   mass	   appears,	   called	  
dysplasia	   (Fig.	   1-­‐B).	   The	   alteration	   in	   tissue	  
homeostasis	   is	   responsible	   to	   elicit	   an	  
inflammatory	  response,	  further	  promoting	  tumor	  
growth	   through	   activation	   of	   surrounding	  
stroma.	  Then,	  with	  additional	  characteristics	  and	  
acquisition	   of	   more	   motile	   and	   migratory	  
phenotype,	  new	  blood	  vessels	  can	  be	   formed	  to	  
better	   feed	   the	   tumor	   cells,	   a	   process	   called	  
angiogenesis.	  Finally,	  during	  metastasis,	  the	  cells	  
invade	   tissue	  and	   forms	   colonies	   at	  distant	   sites	  
(Fig.	  1-­‐C)	  [5].	  	  
The	   homeostatic	   equilibrium	   found	   in	  
normal	   tissues	   is	   disrupted	   by	   tumorigenesis.	  
Under	   normal	   conditions,	   mesenchymal-­‐
epithelial	   interactions	   are	   tightly	   controlled	   so	  
that	  tissue	  integrity	  is	  maintained	  with	  normal	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Figure	  1	  :	  The	  process	  of	  carcinogenesis	  	  [5]	  
	  cell	   proliferation	   and	   turn	   over.	   	   Moreover,	   the	   basement	   membrane	   acts	   as	   a	   barrier	   between	  
supportive	   tissue	   and	   epithelial	   cells.	   The	   fibroblasts,	   inflammatory	   and	   endothelial	   cells	   that	  
compose	  normally	  the	  stroma	  are	  present	  in	  a	  quiescent	  state.	  	  
All	   these	   features	   of	   normal	   epithelia	   are	   disrupted	   by	   carcinogenesis:	   the	   increase	   in	  
proliferation	   of	   tumor	   cells	   leads	   to	   activation	   of	   fibroblasts	   and	   a	   transition	   called	   epithelial	   to	  
mesenchymal	  transition	  (EMT)	  takes	  place	  for	  some	  cells,	  increasing	  their	  motility	  and	  invasiveness,	  
with	  degradation	  of	   basement	  membrane.	   These	  events	   lead	   to	   a	   complete	  disorganization	  of	   the	  
tissue	  with	   loss	  of	   separation	  between	  compartments.	  New	  contacts	  get	  established	  between	  cells	  
with	  direct	  and	  dynamic	  interactions.	  This	  new	  crosstalk	  allows	  the	  tumor	  cells	  to	  turn	  the	  situation	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The	  Microenvironment	  Side	  
The	   tumor	   microenvironment	   comprises	   many	   different	   cells	   beside	   cancerous	   cells.	   It	   is	  
composed	   of	   lymphatic	   and	   vascular	   endothelial	   cells,	   fibroblast	   and	   both	   innate	   and	   adaptive	  
infiltrating	   immune	   cells.	   Extracellular	   matrix	   (ECM)	   and	   basement	   membrane	   also	   belong	   to	   the	  
complex	  organization	  of	   tumor-­‐host	  microenvironment,	   including	  proteoglycans,	   glycoproteins	   and	  
collagens	  (Fig.	  3).	  
Under	   normal	   conditions,	   these	   different	   types	   of	   cells	  maintain	   tissue	   homeostasis	   in	   the	  
different	   organs	   of	   the	   body.	   In	   case	   of	   injury,	   could	   it	   be	   caused	   by	   an	   infection	   or	   an	   intrinsic	  
danger	   signal,	   a	  multifactorial	  network	  of	   chemical	   signals	   induces	  a	   response	   in	  order	   to	  heal	   the	  
afflicted	   tissue.	   Mast	   cells,	   resident	   cells,	   get	   activated	   and	   thus	   send	   signals	   that	   attract	  
macrophages	   and	   immune	   cells	   at	   the	   site	   of	   infection	   [8].	   	   The	   extracellular	   matrix	   serves	   as	   a	  
scaffold	  on	  which	  fibroblasts	  and	  endothelial	  cells	  can	  proliferate	  and	  migrate,	  thus	  forming	  the	  basis	  
for	   reconstruction.	   Mesenchymal	   cells	   such	   as	   fibroblasts	   are	   also	   recruited	   and	   driven	   to	   form	  
collagen.	   New	   blood	   vessels	   are	   also	   built	   and	   the	  whole	   finally	   remodels	   the	   tissue	   to	   “heal	   the	  
wound“.	  	  
	  
While	  under	  normal	  situations	  these	  events	  happen	  normally,	  tending	  toward	  homeostasis	  of	  
tissue	   environment,	   carcinogenesis	   appears	   like	   a	   chaotic	   disorganization	   of	   the	   process	   of	  
inflammation	  and	  repair.	  That	  is	  why	  tumors	  are	  of	  called	  “Wounds	  that	  never	  heal”,	  in	  the	  words	  of	  
Hal	   Dovrak.	   In	   contrast	   with	   the	   organized	   series	   of	   events	   explained	   in	   the	   previous	   paragraph,	  
during	  carcinogenesis,	  this	  disorganization	  prevents	  re-­‐establishment	  of	  homeostasis	  [9].	  	  
	  
	  
Figure	  2:	  The	  tumor	  microenvironment	  [7]	  
	  
At	  the	  beginning,	  both	  stroma	  and	  epithelium	  undergo	  modifications	  promoting	  proliferation	  
and	  amplifying	  mutagenesis	   [8].	  Fibroblasts	  are	  activated	  and	  secrete	  more	  collagen,	  rendering	  the	  
stromal	   reaction	  desmoplastic.	  At	   this	   stage,	   the	  extracellular	  matrix	   changes	   in	   composition,	  with	  
more	  ECM	  proteins	  such	  as	  	  fibronectins,	  collagen	  of	  type	  I	  and	  proteoglycans,	  beside	  higher	  number	  
of	  infiltrating	  immune	  cells.	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Tumor	  –	  Microenvironment	  Interactions:	  Cancer	  related	  inflammation	  
Since	  the	  main	  point	  of	  the	  present	  study	  is	  related	  to	  inflammation,	  a	  more	  detailed	  section	  
is	  devoted	  in	  describing	  the	  different	  aspects	  that	  make	  the	  both,	  tumor	  and	  inflammation,	  so	  tightly	  
linked.	  	  
While	  most	  immune	  mediators	  and	  inflammatory	  cells	  would	  be	  able	  to	  reject	  and	  eliminate	  cancer	  
cells,	   actually	   the	   immune	   system	   gets	   enslaved	   and	   it	   even	   promotes	   tumor	   evolution:	   initiation,	  
promotion	   toward	   malignant	   conversion,	   migration	   and	   metastasis.	   That	   is	   why	   tumor	  
microenvironment	   is	   the	   other	   key	   player	   becoming	   as	   important	   as	   transformed	   cells;	   its	   control	  
and	   a	   deeper	   understanding	   of	   the	   different	   interactions	   will	   certainly	   help	   to	   create	   novel	   and	  
different	  therapeutic	  approaches	  [10].	  	  
Globally,	  two	  pathways	  connect	  cancer	  and	  inflammation.	  First,	  the	   intrinsic	  pathway	  is	  the	  
activation	   as	   a	   result	   of	   genetic	   modifications	   that	   cause	   neoplasia,	   such	   as	   oncogene	   activation.	  
Transformation	  of	  cells	  in	  this	  way	  produces,	  as	  explained	  in	  the	  last	  section,	  inflammatory	  mediators	  
and	  generates	  an	  inflammatory	  microenvironment.	  The	  other	  pathway	  is	  called	  extrinsic	  because	  the	  
cause	  leading	  to	  tumor	  development	  is	  extrinsic	  and	  due	  originally	  to	  viral	  infection.	  At	  some	  point,	  
both	   pathways	   converge,	   since	   the	   same	   state	   is	   reached	   in	   both	   cases.	   Different	   transcription	  
factors	  are	  activated,	  as	  for	  instance	  NF-­‐κB	  or	  STAT3.	  Different	  oncogenes	  are	  also	  activated	  in	  tumor	  
cells	   such	   as	  MYC	   or	   RAS,	   responsible	   for	   the	   stimulation	   of	   transcriptional	   programs	   that	   recruit	  
immune	  cells.	  	  Mediators	  are	  produced	  by	  tumor	  cells	  that	  attract	  immune	  cells	  and	  these	  are	  then	  
modified	  and	  utilized	  by	  cancer	  cells	  so	  that	  the	  basic	  same	  transcription	  factors	  are	  also	  activated,	  
resulting	  in	  an	  auto-­‐amplifying	  loop	  that	  benefits	  tumor	  progression	  and	  cancer-­‐related	  inflammation	  
[11].	  However,	  relationships	  between	  tumor	  and	  immune	  cells	  are	  dynamic.	  With	  time,	  the	  selective	  
pressure	   from	   immune	   system	   induces	   tumor	   cells	   to	   undergo	   a	   process	   that	   is	   called	   immune	  
editing.	   This	   term	   describes	   the	   fact	   that	   tumor	   cell	   become	   resistant	   to	   first-­‐line	   of	   defense	   of	  
immunity	  by	  the	  evolution	  of	  phenotypes	  that	  are	  able	  to	  manipulate	  the	  immune	  cells.	  	  
Inflammation	  and	  neoplastic	  progression	  	  
The	   leukocyte	   population	   of	   a	   developing	   neoplasm	   includes	   dendritic	   cells,	  macrophages,	  
neutrophils,	   eosinophils,	   mast	   cell	   and	   lymphocytes.	   Both	   innate	   and	   adaptive	   immune	   system	   is	  
represented	   and	   each	   cell	   type	   produce	   an	   assortment	   of	   different	  mediators,	   cytokines,	   reactive	  
oxygen	  species,	  serine	  and	  cysteine	  proteases,	  MMPs	  and	  mediators	  of	  cell	  killing	  such	  as	  TNF-­‐α	  and	  
interleukins.	   Here	   following	   is	   described	   in	   details	   the	   creation	   of	   a	   local	   inflammatory	  
microenvironment,	  results	  of	  reciprocal	  and	  dynamic	  interactions	  [15].	  	   	  
	  
Initially,	   cancerous	   cells,	   in	   response	   to	   hypoxia	   and	   necrosis	   secondary	   to	   excessive	   cell	  
proliferation,	  secrete	  different	  chemokines	  and	  cytokines	  that	  attract	  monocytes	  and	  macrophages.	  
The	  latter	  also	  secrete	  growth	  factors,	  such	  as	  VEGF-­‐A	  or	  FGF,	  to	  affect	  tumor	  cells	  behavior,	  but	  also	  
activate	   tumor	   endothelium	   and	   prolong	   inflammation.	   COX-­‐2,	   a	   potent	   stimulator	   of	   cell	  
proliferation,	  survival	  and	  motility	  is	  also	  released	  by	  macrophages	  in	  the	  microenvironment.	  	  
In	  presence	  of	  granulocyte-­‐macrophage	  colony-­‐stimulating	  factor	  (GM-­‐SF)	  and	  interleukin	  IL-­‐
4,	  monocytes	  differentiate	  into	  immature	  dendritic	  cells	  that	  migrate	  into	  inflamed	  peripheral	  tissue	  
to	  capture	  antigens.	  It	  will	  then	  be	  presented	  in	  lymph	  nodes	  to	  T-­‐lymphocytes.	  An	  interesting	  point	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is	   that	   most	   dendritic	   cells	   present	   in	   neoplasms	   are	   defective	   in	   T-­‐cell	   stimulatory	   capacity.	  
Moreover,	   in	  most	  cases,	  adaptive	   immune	  response	   is	   too	  weak	  and	   inefficient	  to	  really	  eradicate	  
tumor	  cells	  [15].	  	  
Another	   important	  component	  of	  neoplastic	   infiltrate	   is	   the	  tumor-­‐associated	  macrophages	  
(TAM).	  Derived	  from	  monocytes,	  TAMs	  have	  a	  paradoxical	  role	  in	  carcinogenesis.	  Although	  IL-­‐2	  and	  
IL-­‐12	  activate	  macrophages	  to	  kill	  tumor	  cells,	  these	  cells	  also	  produces	  different	  potent	  angiogenic	  
and	  lymphangiogenic	  factors	  as	  cytokines,	  growth	  factors	  and	  proteases,	  which	  are	  able	  to	  promote	  
tumor	   progression.	   Macrophages	   are	   also	   responsible	   for	   the	   production	   of	   IL-­‐10,	   a	   mediator	  
molecule	  that	  is	  known	  to	  dissipate	  anti-­‐tumor	  activities	  of	  T	  cells	  [13].	  Macrophage-­‐cancerous	  cells	  
crosstalk	   promotes	   the	   release	   of	  macrophage-­‐derived	   cytokines,	   chemokines	   and	   growth-­‐motility	  
factors.	  This	  works	  in	  an	  auto-­‐amplifying	  loop	  since	  these	  mediators	  recruit	  more	  inflammatory	  cells.	  	  
The	  coordination	  of	  stromal	  response	  to	  cancer	  is,	  among	  other,	  realized	  by	  chemokines	  and	  
cytokines	  present	  in	  the	  microenvironment.	  Both	  polarize	  the	  immune	  response,	  but	  it	  also	  strongly	  
influences	   the	  composition	  of	  cellular	   infiltrate	  and	   is	  described	  to	   induce	  angiogenesis.	  Moreover,	  
their	  corresponding	  receptors	  are	  often	  upregulated	  in	  cancer	  cells	  [15].	  	  
	   The	   stroma	   gets	   rapidly	   infiltrated	   with	   different	   leukocytes	   populations	   and	   this	   can	   be	  
viewed	  as	  a	  double-­‐edged	  sword:	  either	  it	  can	  produce	  cytokines	  that	  work	  to	  inhibit	  tumor	  growth	  
(IL-­‐12	   that	   is	  anti-­‐angiogenic)	  or	   fully	  dedicated	   to	   tumor	  progression.	  The	  abundance	  and	  state	  of	  
activation	   of	   the	   different	   cells	   and	   the	   level	   of	   expression	   of	   different	   immune	   mediators	   and	  
modulators	  balance	  the	  direction	  of	  pro	  or	  anti-­‐tumor	  immunity	  that	  emerges	  there.	  	  
In	  addition,	  as	  inflammation	  is	  sustained,	  non-­‐specific	  pro-­‐inflammatory	  cytokines	  as	  IL1α-­‐β,	  
IL-­‐6	   or	   interferon	   (IFN)-­‐γ	   get	   up-­‐regulated,	   leading	   to	   increased	   transformation	   of	   normal	   cells	  
toward	   pre-­‐neoplastic	   foci.	   The	   transcription	   factor	   NF-­‐κB,	   main	   link	   between	   tumorigenesis	   and	  
inflammation,	  is	  an	  important	  element	  allowing	  cells	  to	  escape	  apoptosis	  [14].	  	  
Many	   tumors	   are	   described	   as	   associated	   with	   the	   activation	   of	   tumor-­‐promoting	   innate	  
immune	   response	   with	   neutrophils	   and	   macrophages,	   while	   on	   the	   other	   hand,	   specific	   adaptive	  
immune	   response	   with	   T	   and	   B	   lymphocytes	   are	   simply	   not	   efficient	   in	   the	   eradication	   of	   tumor	  
niches.	  	  
There	   are	   different	   strategies	   used	   by	   the	   tumor	   cells	   to	   escape	   efficiently	   the	   immune	  
surveillance.	  Down-­‐regulation	  and	  even	   loss	  of	   tumor-­‐associated	  antigens	   (TAA)	   is	  often	  described,	  
as	  well	  as	  the	  use	  of	  immunosuppressive	  cytokines,	  such	  as	  IL-­‐6	  and	  TGF-­‐β.	  These	  mediators	  interfere	  
at	  multiple	   steps	   and	   pathways	   in	   the	   elaboration	   of	   immune	   response	   [12].	   TGF-­‐β	   is	   particularly	  
efficient	  in	  immunosuppression	  by	  affecting	  activation	  and	  differentiation	  of	  immune	  cells.	  Beside	  its	  
role	  on	  immune	  system,	  it	  also	  affects	  tumor	  cells	  by	  increasing	  invasiveness	  and	  stroma	  by	  inducing	  
EMT.	  	  
Focusing	  on	  inflammation:	  the	  NALP3	  Inflammasome	  
Our	   innate	   immune	   system	   has	   evolved	   germline-­‐encoded	   pattern	   recognition	   receptors	  
(PRRs)	  that	  are	  responsible	  for	  the	  recognition	  of	  pathogen-­‐associated	  molecular	  patterns	  (PAMPs):	  
for	   instance,	  Toll-­‐Like	  Receptor-­‐4	   (TLR-­‐4)	   recognizes	  LPS,	  a	  PAMP	  found	  on	  gram-­‐negative	  bacteria.	  
But	  some	  of	  these	  receptors	  are	   interestingly	  also	  able	  to	  recognize	  and	  sense	  endogenous	  signals;	  
these	  are	  like	  intracellular	  counterparts	  of	  TLRs,	  being	  intracellular	  immune	  receptor	  sensing	  danger	  
signals.	  These	  two	  types	  of	  receptors	  cooperate	  to	  initiate	  an	  immune	  response.	  Intracellular	  alarms	  
	   	   10	  
are	   the	   result	   of	   cell	   or	   tissue	   damages	   and	   are	   called	   danger-­‐associated	   molecular	   patterns	  
(DAMPs).	  One	  major	  family	  of	  PRR	  is	  the	  nucleotide-­‐binding	  domain	  leucin-­‐rich	  repeats,	  NLRs.	  These	  
cytosolic	   proteins	   sense	   intracellular	   microbial	   or	   cellular	   danger	   signals	   and	   converge,	   using	  
different	  signaling	  pathways,	   in	  the	  transcription	  of	  cytokines	  and	  chemokines,	  to	  further	  engender	  
proper	   immune	  response	  [16].	   In	  such	  conditions,	  molecules	  that	  would	  normally	  not	  be	  accessible	  
are	   released	   from	   sequestration	   and	   gain	   full	   access	   to	   these	   sensors,	   triggering	   an	   intracellular	  
immune	  response	  of	  defense.	  	  
	  
These	   receptors	  moreover	   take	   part	   in	   the	   formation	   of	   bulky	  molecular	   complexes	   called	  
inflammasomes.	  In	  fact,	   inflammasome	  formation	  and	  activation	  is	  induced	  by	  the	  sensing	  of	  tissue	  
damages	   (DAMPS)	   or	   pathogens	   (PAMPS).	   These	   multiprotein	   complexes	   are	   deeply	   involved	   in	  
immune	  response	  since	  they	  process	  cytokines	  such	  as	  interleukins.	  The	  release	  of	  Interleukin-­‐1β	  is	  
dependent	  upon	  the	  inflammasome	  NALP3	  correct	  formation	  and	  activation.	  	  
That	  is	  why	  we	  particularly	  focused	  on	  this	  given	  inflammasome,	  since	  we	  are	  also	  interested	  




Figure	  3	  :	  Structure	  of	  NALP3	  inflammasome1	  
	  
Having	  the	  same	  basic	  structure	  as	  other	  NLRs,	  the	  NALP3	  protein	  consists	  of	  a	  multidomain	  
assembly	  with	  a	  LRR	  region	  as	  a	  C-­‐terminal,	  a	  central	  nucleotide	  domain,	  a	  NACHT-­‐associated	  NAD	  
domain,	  the	  NACHT	  domain	  and	  a	  N-­‐terminal	  being	  a	  PYRIN	  domain.	  	  
Each	  part	   fulfills	  precise	   tasks.	  The	  LRR	   is	   responsible	   for	   the	   ligand	   sensing	  of	  DAMPS	  and	  
PAMPS	  while	  NACHT	  allows	  the	  oligomerization	  that	  results	  in	  active	  inflammasome.	  NACHT	  contains	  
a	   nucleotide	   binding	   domain	   and	   thus	   binds	  ATP	   and	  dATP,	   sign	   of	   cell	   death	  when	   released.	   PYR	  
facilitate	  dimerization	  with	  corresponding	  PYR	  domains	  in	  other	  proteins	  by	  homotypic	  interactions.	  	  
The	   adaptor	   protein	   ASC	   is	   recruited	   upon	   activation	   of	   NALP3	   protein.	   This	   molecule	  
contains,	   beside	   the	   interacting	   PYR	   domain,	   a	   C-­‐terminal	   CARD	   part	   that	   is	   required	   for	  
inflammasome	   formation.	   It	   is	   necessary	   for	   the	   interactions	   with	   other	   proteins	   the	   complex	  
involves.	   Thus,	   ASC	   recruits,	   via	   the	  CARD	  domain,	   the	   effector	   protein	   that	   is	   the	  Caspase-­‐1,	   also	  
carrying	   the	   required	   CARD	   domain	   that	   interacts.	   The	   formation	   of	   the	   inflammasome	   through	  
these	   different	   interactions	   promotes	   oligomerization	   of	   Caspase-­‐1,	   leading	   to	   the	   induction	   of	   an	  
active	  enzyme	  [19].	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1	  http://www.rndsystems.com/cb_detail_objectname_cb08i1_Caspase1.aspx	  
2	  RNaqueous	  Micro	  Kit	  GUIDE:	  http://www.ambion.com/techlib/prot/fm_1931.pdf	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Caspase-­‐1	  is	  responsible	  for	  the	  cleavage	  of	  the	  cytosolic	  proforms	  of	  IL-­‐1β	  and	  IL-­‐18.	  Pro-­‐IL-­‐
1β	  precursor	  is	  a	  33kD	  protein	  while	  the	  mature	  one	  is	  17kD.	  Active	  Il-­‐1β	  results	  from	  the	  cleavage	  at	  
the	  specific	  Tyr-­‐Val-­‐His-­‐Asp	  site.	  
Concerning	   the	   specific	   stimuli	   activating	  NALP3	   inflammasome,	   the	   assembly	   occurs	   upon	  
sensing	  of	  pathogen-­‐associated	  molecular	  patterns	  (PAMPS),	  nonmicrobial	  danger	  or	  damage	  signals	  
(DAMPS)	   as	   monosodium	   urate	   crystals,	   low	   potassium	   or	   released	   ATP,	   reactive	   oxygen	   species	  
(ROS)	   or	  molecules	   resulting	   from	   lysosomal	   disintegration,	   skin	   irritants	   and	   ultraviolet	   irritation,	  
among	  others	  [17,	  20].	   	  
Basically,	  a	  stimulation	  of	  PRR	  (IL-­‐1R1	  or	  TLR4	  for	  instance)	  induce	  upregulation	  of	  NALP3	  and	  
IL-­‐1β	  expression;	  this	   is	  the	  priming	  step	  (Fig.	  4).	  But	  the	  real	  activation	  of	  the	   inflammasome	  itself	  
requires	   another	   signal	   of	   induction.	   It	  was	   demonstrated	   that	   inflammasome	   is	   not	   constitutively	  
active	   in	   macrophages:	   the	   activation	   of	   NALP3	   in	   such	   cells	   requires	   both	   stimulation	   of	   the	  
synthesis	  of	  the	  proform	  of	  IL-­‐1β	  (via	  the	  NF-­‐κB	  signaling	  cascade)	  and	  a	  signal	  consisting	  of	  efflux	  of	  
potassium:	   a	   sudden	   fall	   in	   intracellular	  potassium	   level	   that	   is	   triggered	  by	  extracellular	  ATP	   [21].	  
The	  pro-­‐Caspase-­‐1	  binds	  only	  then	  the	  complex	  through	  its	  CARD	  domain,	  getting	  thus	  activated.	  The	  
secretion	  of	   processed	  and	  active	   IL-­‐1β	  occurs	   steadily	  within	  hours,	   through	   specialized	   secretory	  
lysosomes	  [17,21].	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Tumor-­‐host	  interactions:	  Interleukin-­‐1	  –	  A	  major	  pleiotropic	  cytokine	  
Cytokines	   have	   cardinal	   and	   dual	   effects	   on	   tumor	   development:	   on	   the	   one	   hand,	   these	  
molecules	  are	  involved	  in	  malignant	  transformation	  and	  tumor	  evolution	  and	  on	  the	  other	  hand,	  they	  
participate	   in	  the	  activation	  of	   immune	  effector	  mechanisms	  that	   limit	  tumor	  growth.	  At	  malignant	  
sites,	   the	   network	   of	   different	   cytokines	   operates	   and	   dictates	   the	   “net	   cytokine	   effect”	   that	  
fluctuates	  depending	  on	  the	  stage	  of	  tumor	  development.	   IL-­‐1	  family	  belongs	  to	  this	  network	  since	  
its	  members	  are	  major	  pleiotropic	  cytokines	  [22,37].	  	  	  
The	   IL-­‐1	   family	   is	   composed	   of	   four	   agonistic	   proteins	   (IL-­‐1α-­‐β,	   IL-­‐18	   and	   IL-­‐33)	   and	   one	  
antagonistic	  protein,	  IL-­‐1Ra,	  the	  IL-­‐1	  receptor	  antagonist.	  	  
By	  binding	   the	   receptor	  without	   transmitting	   an	  activation	   signal,	   the	   IL-­‐1Ra	   reprensents	   a	  
physiological	   inhibitor	  of	   IL-­‐1β.	  Precursors	  are	   synthesized	  as	  31kDa	  proteins,	   further	  processed	  by	  
Caspase-­‐1	   for	   and	   calpain	   into	   mature	   17kDa	   proteins.	   IL-­‐1β	   expression	   and	   secretion	   is	   mainly	  
controlled	  at	  the	  levels	  of	  transcription,	  mRNA	  stability,	  processing	  and	  secretion.	  Mononuclear	  cells	  
are	  the	  major	  productors	  of	  such	  mediators.	  At	  low	  local	  doses,	  secretion	  of	  Il-­‐1β	  provokes	  only	  local	  
immune	  response	  including	  activation	  of	  protective	  immunity,	  while	  higher	  secretion	  doses	  implicate	  
much	  broader	  inflammation	  with	  tissue-­‐damage	  and	  increased	  tumor-­‐invasiveness	  [37].	  Note	  that	  IL-­‐
1α	   secretion	   level	   is	   lower	   than	   for	   IL-­‐1β.	   IL-­‐18	   is	   also	  mainly	   expressed	   in	  macrophages.	   Sharing	  
structural	  homologies	  with	  IL-­‐1β,	  pro-­‐IL-­‐18	  is	  cleaved	  after	  Asp35	  by	  Caspase-­‐1	  too,	  but	  this	  cleavage	  
is	  not	  exclusive,	  meaning	  that	  other	  enzymes	  	  are	  implicated	  [38,39].	  The	  main	  effector	  role	  of	  IL-­‐18	  
is	  the	  induction	  of	  IFN-­‐γ,	  sharing	  many	  intermediate	  mediators	  with	  the	  IL-­‐1β	  cascade.	  Concerning	  IL-­‐
33,	  its	  proform	  is	  also	  processed	  by	  caspase-­‐1	  and	  the	  mature	  form	  is	  shown	  to	  signal	  through	  the	  IL-­‐
1R4	  to	  activate	  the	  NF-­‐κB	  signaling	  cascade[40].	  	  
On	   the	   side	   of	   the	   receptors,	   IL-­‐1Rs	   are	   members	   of	   the	   immunoglobulin	   (Ig)	   supergene	  
family.	  This	  kind	  of	  receptors	  are	  abundantly	  and	  constitutively	  expressed	  on	  many	  cell	  types.	  IL-­‐1R1	  
is	   the	   signaling	   receptor,	   while	   IL-­‐1R2	   is	   a	   secreted	   decoy	   receptor,	   acting	   to	   reduce	   excessive	  
amount	  of	  IL-­‐1	  in	  the	  microenvironment	  [22].	  	  
	  
The	   signaling	   cascade	   works	   as	   follow:	   upon	   binding	   of	   IL-­‐1β	   to	   IL-­‐1R1,	   a	   ligand-­‐induced	  
conformational	   change	   in	   the	  extracellulare	  domain	  of	   the	   receptor	   facilitates	   the	   recruitement	  of	  
the	  IL-­‐1R	  acceptor	  protein	  (IL-­‐1RAcP):	  an	  heterodimeric	  complex	  forms	  to	  transduce	  the	  signal.	  This	  
complex	   leads	   to	   the	   activation	   of	   the	   IL-­‐1	   receptor	   associated	   kinase,	   the	   IRAK	   protein,	   and	   also	  
recruits	   the	   intracellular	   signaling	  molecule,	  MYD88	   [22].	   These	   events	   form	   a	   stable	   IL-­‐1-­‐induced	  
first	   signaling	  module.	  The	  cascade	   leads	   in	   the	  end	   to	  activation	  of	  nuclear	  genes,	  mainly	   through	  
nuclear	   factor	   NF-­‐κB	   cascade:	   the	   inhibitor	   of	   nuclear	   factor	   B	   (IκB)	   has	   to	   be	   degraded	   as	   a	  
downstream	   step	   of	   the	   cascade	   to	   release	   p50	   and	   p65	   NF-­‐κB.	   These	   subunits	   are	   then	   able	   to	  
translocate	  into	  the	  nucleus	  to	  bind	  conserved	  DNA	  motifs.	  In	  the	  presence	  of	  IL-­‐1R2	  and	  IL-­‐1Ra,	  the	  
heterodimeric	  complex	  can	  not	  form	  and	  no	  downstream	  activation	  can	  occur.	  	  
	  
These	   alarm	   cytokines	   are	   mainly	   secreted	   by	   macrophages	   to	   initiate	   inflammation	   and	  
induce	  the	  expression	  of	  pro-­‐inflammatory	  genes	  such	  as	  COX2	  or	  IL-­‐6.	  Moreover,	  IL-­‐1	  stimulates	  its	  
own	  production,	  giving	  rise	  to	  an	  autoamplifiying	  loop	  of	  the	  imflammatory	  response,	  in	  an	  autocrine	  
or	   paracrine	  manner.	   In	  macrophages,	   an	   unique	   IL-­‐1	   promoter	   chromatin	   structure	   allows	   a	   very	  
rapid	  cytokine	  production.	  The	  gene-­‐regulatory	  actions	  of	  IL-­‐1	  use	  a	  conserved	  signaling	  system	  and	  
this	  relies	  on	  rapid	  and	  transient	  assembly	  of	  different	  complexes.	  	  Additionally,	  IL-­‐1	  family	  members	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have	  potentiating	  effects	  on	  proliferation	  of	  many	  different	   types	  of	   cells,	   such	  as	  T	  and	  B	   cells	  or	  
macrophages[22].	   At	   early	   stages	   of	   carcinogenesis,	   the	   role	   of	   IL-­‐1	   on	   cell	   transformation	   is	  
important	   since	   these	   mediator	   molecules	   produce	   growth	   factors	   for	   the	   tumor	   cells.	   They	   also	  
generate	  reactive	  oxygen	   intermediate,	   therefore	  potentiating	  mutatgenesis	   in	  resident	  cells	  at	  the	  
tumor	   site.	   Recent	   studies	   have	   shown	   correlation	   between	   IL-­‐1	   expression	   in	   tumor	   cells	   	   and	  
oncogene	  activations	  so	  that	  IL-­‐1	  works	  in	  an	  autocrine	  fashion	  [24,	  23].	  	  
	  
	  
Figure	  5:	  Steps	  in	  the	  synthesis	  and	  secretion	  of	  IL-­‐1β	  induced	  by	  IL-­‐1β	  [37]	  
A	   mouse	   model	   of	   melanoma	   hepatic	   metastasis	   was	   used	   to	   assess	   the	   role	   of	   stroma-­‐
derived	   IL-­‐1	   in	  promoting	  metastasis.	  Vanaclocha	  et	  al.	  could	  demonstrate	  the	  potentiation	  of	   liver	  
metastases	   following	   intrasplenic	   injection	   of	   recombinant	   IL-­‐1β	   or	   LPS	   (inducer	   of	   IL-­‐1β).	   On	   the	  
other	   hand,	   the	   treatment	   with	   IL-­‐1Ra	   could	   reduce	   metastases	   and	   increase	   the	   survival	   rates.	  
Another	  model	  of	  IL-­‐1β	  KO	  mice	  also	  showed	  reduced	  liver	  metastasis	  for	  B16-­‐F10	  melanoma	  cells.	  
These	   cells	   induce	   the	   production	   and	   secretion	   by	   the	   endothelial	   cells	   of	   IL-­‐1β,	   TNFα	   and	   IL-­‐18,	  
these	  molecules	   being	   particularly	   efficient	   in	   the	   upregulation	   of	   adhesion	  molecule’s	   expression	  
[25,26].	  	  	  
It	  was	  also	  demonstrated	   that	   lymphoreticular	  organs	   such	  as	   liver,	   lungs,	   skin	  and	   spleen,	  
being	  like	  ports	  of	  entry	  of	  pathogens,	  shows	  high	  IL-­‐1	  expression	  while	  internal	  organs	  such	  as	  brain	  
or	  kidney	  have	  a	   lower	   IL-­‐1	  expression.	   It	   could	  be	  deduced	  that	  a	  higher	   IL-­‐1	  expression	   is	  due	   to	  
fact	   that	   it	  deserve	  a	   role	  of	  defence	  at	   these	   sites,	   even	  at	   the	   cost	  of	   tissue-­‐damage	   [27,28].	  An	  
intersting	   point	   is	   that	   much	   less	   is	   described	   concerning	   the	   role	   of	   IL-­‐1	   receptors,	   especially	  
concerning	  the	  expression	  level	  on	  tumor	  cells,	  but	  also	  on	  concerned	  immune	  cells.	  	  Different	  open	  
questions	  that	  still	  require	  further	  investigations.	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MicroRNAs:	  new	  regulators	  of	  immunity	  	  
MicroRNAs,	  miRNAs,	  are	  small,	  noncoding	  RNAs	  of	  about	  22	  nucleotides	  in	  length.	  These	  are	  
mediators	  of	  RNA	  interference,	  representing	  a	  novel	  mechanism	  controlling	  expression	  of	  proteins	  at	  
the	   translational	   level	   [30].	   Involved	   in	   different	   processes	   important	   for	   development,	   cell	  
differentiation	   or	   cell	   cycles,	   their	   expression	   is	   deregulated	   in	   cancer.	   A	   variety	   of	  mechanisms	   is	  
involved	  here:	  epigenetic	  silencing,	  insertion-­‐deletion,	  amplifications	  or	  mutations.	  A	  striking	  point	  is	  
that	  almost	  half	  of	  know	  miRNAs	  are	   located	   inside	  or	  close	   to	   fragile	  sites	  or	  common	  breakpoint	  
sites	   that	  are	  associated	  with	  cancer.	  Moreover,	  miRNAs	  signatures	  of	  different	  malignancies	  were	  
also	   described,	   showing	   the	   real	   influence	   these	   molecules	   have	   in	   tumor	   progression	   and	   the	  
importance	  of	  understanding	  the	  underlying	  mechanisms	  [31].	  	  	  
A	  few	  words	  about	  their	  biogenesis	  first.	  The	  miRNAs	  are	  transcribed	  by	  the	  RNA	  polymerase	  
II	   and	   the	   primary	   transcript	   is	   of	   variable	   length,	   called	   the	   pri-­‐miRNA.	   The	   Drosha	   RNase	   II	  
recognizes	   this	  molecule	   and	   cleaves	   it	   in	   the	  nucleus,	   resulting	   in	   a	   hairpin	   precursor	   form	   called	  
pre-­‐miRNA	  (Fig.	  6.a).	  Then,	  the	  pre-­‐miRNA	  is	  exported	  by	  exportin4	  and	  Dicer	  processes	  it	  to	  form	  a	  
transient	   and	   short	   20	   nucleotides	   duplex	   (Fig.	   6.c).	   RISC	   is	   a	   large	   protein	   complex,	   RNA-­‐induced	  
silencing	   complex,	   that	   incorporates	   only	   one	   strand	   of	   the	   formed	   duplex.	   Finally,	   the	   mature	  
miRNA	  loaded	  on	  RISC	  induces	  translational	  repression	  of	  the	  target	  mRNA,	  with	  a	  level	  of	  repression	  
depending	  on	  the	  degree	  of	  complementarity	  between	  the	  miRNA	  and	  its	  target	  (Fig.	  6.d).	  
	  
Figure	  6:	  MicroRNAs	  Biogenesis	  [31]	  
Different	  microRNAs	  were	  described	  for	  their	   involvement	  in	   immune	  response’s	  regulation	  
and	  immune	  cell	  maturation	  [30].	  Here	  we	  are	  particularly	  interested	  in	  the	  miRNAs	  that	  regulate	  the	  
cascade	   of	   signaling	   downstream	   of	   the	   Il-­‐1R1	   receptor.	   MiR-­‐146a	   was	   described	   to	   be	   very	  
important	  in	  macrophages	  to	  regulate	  the	  loop	  of	  signaling	  involved	  in	  response	  to	  IL-­‐1β	  stimulation.	  
Upon	  binding	  of	  the	  ligand,	  as	  explained	  in	  the	  previous	  section,	  the	  signaling	  cascade	  activates	  the	  
kinase	  IRAK.	  This	  induces	  the	  activation	  of	  the	  downstream	  effector	  NF-­‐κB,	  leading	  to	  expression	  of	  
	   	   15	  
genes	   involved	   in	   immune	  response,	  with	   inflammatory	  meditors	  released.	   In	  macrophages,	  by	  the	  
same	  time,	  miR-­‐146a	  expression	  is	  induced	  following	  activation	  of	  TLR-­‐2,	  -­‐4	  and	  -­‐5,	  upon	  exposure	  to	  
TNFα	   or	   IL-­‐1β.	   Interestingly	   and	   logically,	   this	   is	   NF-­‐κB	   that	   is	   responsible	   for	   its	   transcriptional	  
regulation	   (Fig.	  7).	   The	  expression	  of	  miR-­‐146a	   is	   then	   linked	   to	   the	   inhibition	  of	   the	   IRAK-­‐	  TRAF6-­‐	  
IKK-­‐	  NF-­‐κB	  signaling	  cascade	  that	  gets	  downregulated	  upon	  expression	  of	  this	  microRNA	  [32,33].	  miR-­‐
146b	  is	  induced	  upon	  LPS	  addition	  in	  macrophages	  cultures,	  and,	  certainly,	  other	  stimulators	  are	  still	  
unknown.	  	  
	  
Figure	  7:	  Roles	  of	  miR-­‐146a	  and	  miR-­‐155	  in	  regulation	  of	  inflammatory	  mediator	  release	  [30]	  
We	  have	   the	   compelling	   evidences	   that	  miRNAs	   are	   involved	   in	   the	   regulation	   of	   immune	  
response	   and	   this	   opens	   us	   new	   doors:	   a	   deeper	   understanding	   of	   their	   involvment	   in	   signaling	  
cascades	   and	   modes	   of	   action	   would	   ultimately	   give	   us	   new	   tracks	   to	   explore	   and	   define	   new	  
therapeutic	  approaches	  in	  the	  treatment	  of	  cancer	  related	  inflammation.	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AIM	  OF	  THE	  STUDY	  	  
	  
Inflammation	  is	  a	  critical	  player	  in	  tumor	  evolution	  with	  inflammatory	  cells	  orchestrating	  the	  
neoplastic	   process.	   	   In	   particular	   regarding	   the	   inflammasome	   cascade,	   several	   studies	   could	  
highlight	  the	  manipulations	  that	  tumor	  cells	  operate:	   	   the	  constitutive	  activation	  of	  NALP3	  and	   IL-­‐1	  
receptor	   signaling	   lead	   to	   continuous	   secretion	   of	   IL-­‐1β,	   thus	   exhibiting	   features	   of	   auto-­‐
inflammatory	  diseases.	  Moreover,	  previous	  studies	  carried	  out	  in	  the	  lab	  highlighted	  the	  implication	  
of	   NALP3	   in	   the	   processes	   of	   tumor	   growth	   and	   metastasis.	   Indeed,	   since	   tumor	   growth	   and	  
metastases	   number	   are	   strongly	   decreased	   in	   NALP3-­‐knockdown	  mice	   in	   comparison	   to	  wild-­‐type	  
positive	  control	  mice,	  it	  could	  imply	  that	  NALP3	  plays	  an	  important	  role	  in	  tumor	  evolution,	  especially	  
in	  growth	  and	  survival	  of	  neoplastic	  cells	  at	  both	  primary	  and	  secondary	  sites.	  	  	  
	   Thus,	  the	  framework	  of	  the	  study	  could	  be	  set	  to	  investigate	  the	  mechanistic	  implications	  of	  
NALP3	  in	  tumor-­‐host	  interactions,	  in	  particular	  in	  the	  metastatic	  process.	  To	  appropriately	  study	  the	  
influence	   of	   the	  NALP3	   knockdown	   immune	   system,	   two	   cell	   lines,	   described	   below,	  were	   chosen	  
because	   of	   their	   properties	   toward	   the	   inflammatory	   context.	   Concerning	   growth	   and	  metastasis,	  
while	   LLC-­‐B6	   cells	   are	  hardly	  disadvantaged	   in	  a	  NALP3	  knockdown	  context	   compared	   to	   the	  wild-­‐
type	   one,	   B16-­‐F10	  melanoma	   cells	   growth	   and	   propagation	   is	   severely	   impaired	   upon	   injection	   in	  
NALP3	   knockdown	   mice.	   This	   difference	   could	   be	   exploited	   in	   order	   to	   further	   determine	   what	  
component	  of	  signaling	  cascade	  represents	  a	  targetable	  point	  in	  the	  pathway.	  	  
More	  specifically,	  these	  two	  types	  of	  cells	  were	  used	  to	  perform	  different	  in	  vitro	  assays.	  First	  
of	  all,	  expression	  levels	  of	  different	  specific	  genes	  were	  assessed	  in	  both	  tumor	  cell	  lines,	  as	  well	  as	  in	  
macrophages	  of	  different	  NALP3	  genetic	  background.	  These	  analyses	  led	  us	  to	  further	  investigate	  the	  
role	   of	   IL-­‐1R1,	   since	   both	   tumor	   cell	   lines	   expressed	   very	   different	   level	   of	   this	   receptor.	   The	  
hypothesis	  of	  the	  implication	  of	  this	  receptor	  in	  the	  promotion	  or	  not	  of	  growth	  and	  metastasis	  was	  
assessed.	  The	  knockdown	  but	  also	   the	  overexpression	  of	   this	   receptor	  on	   tumor	   cells	  was	   realized	  
using	  standard	  cloning	  techniques.	  It	  allowed	  further	  in	  vitro	  and	  in	  vivo	  tests.	  	  
	  
In	   another	   experiment,	   co-­‐cultures	   of	   tumor	   cells	   and	   macrophages	   of	   different	   NALP3	  
genetic	  background	  were	  performed	  to	  assess	  the	  profile	  of	  gene	  expression	  of	  both	  cell	  lines	  and	  of	  
macrophages,	   using	   microarrays.	   Furthermore,	   laser	   capture	   microdissection	   allowed	   precise	  
extraction	   of	   total	   RNA	   of	   B16-­‐F10	  metastases	   from	   lungs	   of	   either	   NALP3	  wild-­‐type	   or	   knockout	  
mice.	  The	  purpose	  of	  this	  experience	  is	  to	  elucidate	  adaptation	  mechanisms	  of	  the	  tumor	  cells	  being	  
in	  contact	  with	   two	  different	   inflammatory	  contexts,	  by	  performing	  microarrays	  analysis.	  Extracted	  
material	   could	   also	   be	   used	   to	   study	   differential	   expression	   of	   miRNAs	   regarding	   inflammatory	  




	   	   17	  
3.	  MATERIALS	  AND	  METHODS	  	  
	   3.1	  Cell	  lines	  used	  	  
	  
Melanoma	  cell	  line:	  B16	  –F10	  
	  
The	   B16-­‐F10	   cell	   line	   is	   a	  murine	  melanoma	  of	   C57BL6	   origin.	  Upon	   injection	   in	   syngeneic	  
immunocompetent	  hosts,	  these	  cells	  establish	  metastases	  at	  different	  sites	  as	  for	  instance	  lungs	  and	  
liver.	  These	  are	  thus	  widely	  used	  to	  study	  mechanisms	  of	  metastases	  propagation	  and	  other	  features	  
of	   tumor	   migrations.	   Morphologically,	   the	   tumors	   and	   metastasis	   formed	   are	   more	   compact	   and	  
rounder	  than	   in	  the	  case	  of	  LLC-­‐B6	  cells,	  described	  below,	  and	  fully	  adherent	   in	  culture.	  Moreover,	  
these	   cells	   are	   easy	   and	   convenient	   to	   culture,	   being	   extended	   quite	   rapidly	   and	   not	   demanding	  
special	   culture	   conditions.	   A	   standard	   medium	   is	   used,	   composed	   of	   Dulbecco's	   modified	   Eagle's	  
medium	  (DMEM)	  with	  4.5%	  glucose	  supplemented	  in	  FBS	  (10%),	  NEAA	  and	  P/S	  (1%	  each),	  put	  at	  37°C	  
in	  a	  humidified	  atmosphere	  of	  95%	  air	  and	  5%	  CO2.	  
This	   cell	   line	   was	   chosen	   in	   this	   study	   because	   of	   their	   dependency	   on	   the	   inflammatory	  
micro-­‐environment:	  there	  are	  evidences	  (from	  previous	  studies	  assessed	  in	  our	  lab)	  that	  in	  a	  normal	  
inflammatory	   microenvironment,	   B16-­‐F10	   metastases	   can	   propagate	   with	   ease,	   while	   in	   a	   NALP3	  
knock	  out	  context,	  with	  much	  less	  mature	  IL-­‐1β	  present	  in	  the	  stroma,	  their	  propagation	  is	  severely	  
impaired.	  These	  results	  concord	  with	  previous	  studies	  explained	  in	  the	  introductory	  part	  [25,	  26].	  	  
	  	  
Lewis	  Lung	  Carcinoma	  cell	  line:	  LLC–B6	  
	  
The	  Lewis	  Lung	  Carcinoma	  cell	  line	  was	  discovered	  by	  Dr.	  Margaret	  Lewis	  in	  1951	  in	  the	  same	  
mouse	  background	  C57BL6.	  Appearing	  like	  a	  semi-­‐firm	  homogenous	  mass,	  they	  form	  widespread	  and	  
highly	   invasive	  tumors	  and	  metastasis	  well	  disseminated	  all	  around	  the	   lung.	  Morphologically,	   they	  
are	   semi-­‐adherent	   in	   culture	   dish,	   smaller	   in	   size	   compared	   to	   other	   cells	   such	   as	   B16-­‐F10	   and	  
require	   standard	   cell	   culture	  medium.	   This	   cell	   line	   is	   also	  widely	   used	   as	   a	   transplantable	  murine	  
carcinoma	  to	  provide	  a	  model	  for	  the	  study	  of	  early	  events	  during	  metastasis	  development	  [36].	  	  
LLC-­‐B6	  were	  chosen	  to	  be	  used	  in	  the	  study	  because	  basically	  these	  cells	  are	  opposed	  to	  B16-­‐
F10	   in	   terms	   of	   dependency	   on	   immune	   system.	   Their	  metastases	  were	   quite	   independent	   of	   the	  
inflammatory	   context,	  may	   it	   be	   from	   immune	   system	   itself	   or	   even	   its	   activation.	   In	   a	   context	   of	  
deficient	   Il-­‐1β	   secretion	   as	   in	   the	   case	   of	   a	   NALP3	   knockout	  mouse,	   these	   cells	   were	   still	   able	   to	  
metastasize,	  even	  if	  slightly	  less	  than	  in	  the	  wild	  type	  case.	  	  
	  
	  
These	   two	   cell	   lines	   are	   thus	   very	   different	   in	   their	   mode	   of	   propagation,	   regarding	   the	  
inflammatory	   context.	   This	   is	  why	  we	   reckon	   it	   could	  be	   interesting	   to	  asses	  both	   types	  of	   cells	   in	  
different	  experiment,	  playing	  with	  the	  genetic	  background	  governing	  the	  inflammatory	  response	  in	  in	  
vivo	  experiments.	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Macrophages	  
	  
Macrophages,	  white	  blood	  cells	  resulting	  from	  differentiation	  of	  monocytes,	  are	  important	  immune	  
cells	   that	   function	   in	   both	   lines	   of	   defense:	   innate	   and	   adaptive	   immunity.	   Having	   a	  main	   role	   of	  
phagocytosis	  through	  ingestion	  and	  digestion	  of	  pathogens	  or	  cellular	  debris,	  these	  cells	  also	  secrete	  
different	  factors	  like	  cytokines	  such	  as	  Il-­‐1β	  that	  stimulate	  and	  attract	  other	  immune	  cells.	  Basically,	  
they	  represent	  the	  standard	  and	  first	  immune	  cells	  encountered	  as	  soon	  as	  an	  immune	  response	  has	  
to	   be	   hired.	   That	   is	   why	   we	   choose	   these	   cells	   to	   kind	   of	   mimic	   the	   inflammatory	   context,	   and	  
moreover	  because	  these	  are	  the	  main	  cells	  secreting	  the	  pro-­‐inflammatory	  cytokine	  involved	  in	  our	  
genetic	   model,	   the	   Il-­‐1β.	   To	   induce	   the	   cell	   activation	   and	   secretion	   of	   cytokines,	   it	   was	  
demonstrated	  that	  different	  PAMPS	  work	  very	  well,	  such	  as	  LPS	  and/or	  ATP	  [34].	  	  	  
Practically,	  macrophages	   can	  be	   freshly	   extracted	   from	  mice	   following	   specific	   guidelines.	   Because	  
under	   normal	   conditions,	   the	   number	   of	  macrophages	   that	   can	   be	   extracted	   in	   the	   peritoneum	   is	  
quite	   low,	   an	   irritant	   is	   necessary	   to	   engender	   a	   local	   inflammation	   and	   a	   recruitment	   of	   immune	  
cells.	  	  To	  do	  so,	  1ml	  of	  heated	  thioglycolate	  3%	  in	  distilled	  water	  is	  injected	  intraperitoneously.	  This	  
chemical	   irritant	   will	   thus	   induce	   an	   immune	   response	   with	   attraction	   and	   differentiation	   of	  
monocytes.	   4	   days	   later,	   few	   millions	   macrophages	   can	   be	   harvested	   per	   mouse:	   	   the	   mice	   are	  
sacrificed	  and	  2ml	  of	  cold	  (4°C)	  PBS	  (Phosphate	  Buffer	  Saline)	  is	  injected	  directly	  into	  the	  peritoneum.	  
The	  contrast	  of	  temperatures	  induces	  the	  detachment	  of	  macrophages	  from	  tissues	  and	  the	  solution	  
enriched	   in	   immune	   cells	   can	   then	   be	   retrieved.	   After	   3-­‐4	   washes	   like	   this,	   recovered	   liquid	   is	  
centrifuged	   and	   an	   erythrolysis	   is	   performed	   using	   a	   hypotonic	   solution.	   Macrophages	   are	   then	  
selected	  through	  their	  strong	  adhesion	  ability:	  2	  hours	   incubation	   in	  RPMI-­‐1640	  medium,	  ATB-­‐ATM	  
(1%),	   and	   Hepes	   (1M)	   allows	   these	   cells	   to	   adhere	   to	   the	   culture	   plate.	   The	   supernatant	   is	   then	  
changed,	  removing	  all	  cells	  that	  did	  not	  attach,	  and	  the	  complete	  medium	  is	  added,	  supplemented	  in	  
10%	   Heat-­‐Inactivated	   (HI)	   FCS,	   gentamicin	   (0.1%),	   non-­‐essential	   amino	   acids	   (1%)	   and	   β-­‐
mercaptoethanol	  (0.035%).	  	  
In	  the	  present	  study,	  mouse	  peritoneal	  macrophages	  were	  used	  in	  vitro	  in	  order	  to	  kind	  of	  mimic	  the	  
inflammatory	  microenvironment	   through	   secretion	   of	   cytokines	   such	   as	   Il1-­‐β.	   Different	  molecules	  
known	   to	   induce	   the	   formation	  of	  NALP3	   inflammasome	  were	  used	   in	  order	   to	   check	   the	  possible	  
activation	  of	  macrophages	  and	  to	  induce	  their	  secretion	  of	  these	  cytokines:	  	  
 LPS:	   	   lipopolysaccharides	  functioning	   in	  the	  outer	  membrane	  of	  Gram-­‐negative	  bacteria	  
and	  acting	  as	  an	  endotoxin,	  is	  a	  PAMP	  known	  to	  elicit	  a	  strong	  immune	  response	  [34]	  
o Added	  at	  a	  concentration	  of	  1mg/mL	  for	  18h	  
 ATP:	  	  adenosine	  triphosphate,	  being	  the	  coenzyme	  used	  as	  an	  energy	  carrier	  in	  the	  cells,	  
that,	  when	  present	  in	  the	  extracellular	  matrix,	  can	  also	  induce	  activation	  of	  macrophages	  
[35]	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3.2	  Techniques	  Used	  
	  
IN	  VITRO	  TECHNIQUES	  	  
	  
	  	  Co-­‐cultures	  	  
	  
In	  order	  to	  model	  the	  inflammatory	  microenvironment,	  we	  decided	  to	  co-­‐culture	  tumor	  cells	  
with	  activated	  macrophages.	  The	  Transwell	   inserts	   (Corning)	  allow	  co-­‐culturing	  two	  cell	   lines	   in	  the	  
same	  well	  by	  the	  use	  of	  an	  insert	  forming	  the	  upper	  compartment	  (Fig.	  8).	   	  The	  thin	  polycarbonate	  
membrane	  at	  the	  basis	  of	  this	  insert	  is	  permeable	  to	  soluble	  secreted	  factors	  and	  not	  to	  cells	  (0.4µm	  
pores):	  only	  secreted	  molecules	  are	  able	  to	  cross	  the	  membrane	  and	  act	  on	  tumor	  cells.	  
	  
	  
Figure	  8	  :	  Depiction	  of	  Transwell	  inserts	  used2	  
	  
Tumor	  cells	  were	  grown	  in	  the	   lower	  compartment	  while	  the	  macrophages	  were	  put	   in	  the	  
insert.	  It	  is	  basically	  a	  good	  standard	  model,	  especially	  convenient	  for	  RNA	  extraction,	  since	  the	  two	  
cell	  populations	  are	  not	  mixed.	  However,	  the	  main	  drawback	  is	  the	  fact	  that	  the	  cells	  are	  not	  in	  direct	  
contact	  as	  in	  the	  real	  context,	  changing	  and	  thus	  lacking	  all	  the	  contact	  interactions	  and	  reactions.	  
	  
Macrophages	   from	   both	   background,	   NALP3	   KO	   or	   WT,	   were	   used	   to	   compare	   both	  
conditions.	  Briefly,	  150	  000	  freshly	  extracted	  macrophages	  were	  seeded	  and,	  after	  2	  hours	  required	  
for	  attachment,	  the	  medium	  was	  removed	  and	  washed	  2	  times	  with	  PBS	  and	  	  200µl	  of	  the	  complete	  
macrophage	  medium	  was	  added.	  At	  the	  same	  time,	  the	  same	  number	  of	  tumor	  cells	  is	  seeded	  in	  the	  
lower	   compartment.	   8	   hours	   later,	   the	   LPS	   and/or	   ATP	   were	   added	   as	   described	   for	   18h	   or	  
30minutes,	  respectively,	   in	  order	  to	  activate	  the	  macrophages	  and	  induce	  the	  normal	  inflammatory	  
response,	   therefore	   mimicking	   the	   inflammatory	   context.	   Both	   type	   of	   cells,	   tumor	   cells	   and	  
macrophages,	  were	   recovered	   thereafter	   using	  different	   lysis	   buffer	   in	  order	   to	   extract	   total	   RNAs	  
and	  supernatant	  was	  kept	  to	  perform	  Western	  Blot	  analysis.	  	  
	  
	  RNA	  isolation	  	  
	  
Extraction	  	  
RNA	   extraction	   was	   performed	   differently	   regarding	   the	   quantity	   of	   cells	   available.	  	  
For	   the	   co-­‐cultures	  where	   the	  number	  of	   tumor	   cells	  was	   sufficiently	   high	   (500’000	   cells)	   to	  use	   a	  
	   	   20	  
standard	   kit,	   the	   RNeasy®	   Mini	   Kit	   was	   chosen,	   appropriate	   for	   micrograms	   of	   RNA.	   For	   the	  
macrophages	   in	   co-­‐cultures,	   since	   their	   number	   was	   much	   lower	   (150’000	   cells)	   because	   of	   their	  
nonproliferative	  state,	  and	  for	  the	  tissue	  samples	  extracted	  with	   laser	  capture	  microdissection	  (see	  
below),	  the	  RNaqueous	  Micro	  Kit	  was	  more	  suitable	  since	  it	  is	  optimized	  for	  recovery	  of	  total	  cellular	  
RNA	  from	  pico-­‐samples.	  In	  both	  cases,	  RNA	  extraction	  was	  performed	  according	  the	  manufacturer’s	  
instructions:	  
RNeasy®	  Mini	  Kit	  Protocol	  (Qiagen)	  
First,	   a	   lysis	   buffer	   containing	   β-­‐mercaptoethanol	   is	   applied	   to	   the	   cells,	   pelleted	   or	   in	   the	  
wells,	  for	  membrane	  disruption	  and	  RNases	  inactivation.	  The	  obtained	  lysate	  is	  then	  homogenized	  by	  
passing	   through	   a	   spin	   column	   that	   removes	   all	   undisrupted	   elements.	   The	   addition	   of	   ethanol	   is	  
then	  used	   to	  provide	  optimal	  binding	  conditions	   to	   the	  silica-­‐based	  membrane	   for	   the	  second	  spin	  
step,	  carried	  out	  to	  allow	  total	  RNA	  to	  attach	  to	  the	  silica-­‐based	  membrane.	  Finally,	  different	  washes	  
are	   made	   to	   remove	   other	   contaminants	   from	   the	   membrane	   and	   RNase	   Free	   water	   is	   applied	  
directly	  to	  the	  spin	  column	  to	  elute	  RNA.	  	  	   	  	  
RNaqueous®	  Micro	  Kit	  Protocol	  (Ambion)	  
This	  kit	  is	  optimized	  for	  extraction	  of	  RNA	  from	  micro	  sized	  samples:	  10	  mg	  of	  tissue	  or	  even	  
10	   microdissected	   cells	   are	   sufficient.	   The	   other	   specialty	   is	   the	   filter	   cartridge	   that	   is	   designed	  
specifically	  for	  very	  small	  samples.	  
In	  a	  few	  words,	  it	  uses	  a	  powerful	  chaotropic	  guanidinium	  thiocyanate	  solution	  to	  solubilize	  
samples:	  it	  effectively	  lyses	  cells	  and	  inactivates	  endogenous	  ribonucleases.	  Ethanol	  is	  then	  added	  to	  
dilute	  the	  lysate:	  this	  step	  offers	  the	  possibility	  to	  extract	  both	  large	  and	  small	  RNA	  species	  as	  tRNAs,	  
rRNA,	  and	  microRNAs	  or	  only	  large	  RNAs.	  Then,	  the	  mix	  is	  applied	  to	  an	  RNA-­‐binding	  glass	  fiber	  filter	  
and	  three	  washing	  steps	  remove	  proteins,	  DNA	  and	  other	  contaminants.	  Finally,	  the	  bound	  RNA	  can	  
be	  eluted	  and	  concentrated	  in	  a	  minimal	  volume	  of	  20	  µl.	  The	  kit	  also	  offers	  the	  possibility	  to	  remove	  
genomic	  DNA	  by	  using	  the	  DNA-­‐free	  system2.	  
	   	  
Quantity	  and	  purity	  determination	  	  
RNA	  quantity	  and	  purity	  were	  assessed	  with	  the	  NanoDrop®	  ND-­‐1000	  spectrophotometer	  of	  
NanoDrop	  Technologies	  Company,	  USA.	  	  
This	   spectrophotometer	   measures	   absorbance	   of	   a	   solution:	   a	   pulsed	   xenon	   flash	   lamp	  
provides	  light	  source	  of	  given	  wavelength,	  this	  light	  passes	  through	  the	  solution	  and	  is	  collected	  in	  a	  
spectrophotometer	  that	  analyzes	  it	  thereafter.	  	  
Briefly,	   the	   Beer-­‐Lambert	   equation	   describes	   this	   phenomenon:	   the	   correlation	   of	   the	  
absorbance	  of	   the	   solution	  with	   the	   concentration	  of	   substances	   in	   this	   solution,	   at	  wavelength	  at	  
which	   these	  absorb	   light.	  Note	   that	   this	   instrument,	  with	   full-­‐spectrum	  from	  220	  nm	  to	  750	  nm,	   is	  
able	  to	  measure	  very	  small	  samples	  (1	  µl)	  with	  very	  high	  accuracy,	  a	  good	  point	  since	   it	  enables	  to	  
minimize	  loss	  of	  samples.	  Mathematically,	  it	  is	  as	  follow:	  	  
	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
2	  RNaqueous	  Micro	  Kit	  GUIDE:	  http://www.ambion.com/techlib/prot/fm_1931.pdf	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! = !o	  !!!"# 	   	   Beer’s	  Law	  
	   	   Where:	  	   I	  and	  Io	  =	  Intensity	  collected	  and	  intensity	  emitted	  
	   	   	   	   C=	  concentration	  [mol	  /	  L]	  
	   	   	   	   L	  =	  length	  of	  the	  optical	  path	  [cm]	  
	   	   	   	   ε	  =	  molar	  absorptivity	  	  ,	  in	  function	  of	  wavelength	  	  [L/mol/cm]	  
	   	   and	  to	  find	  the	  concentration	  we	  get:	  	  	  	  c	  =	  
–!"  ( !!!  )!  ! 	  	  
	  
The	   other	   two	   main	   indications	   we	   get	   from	   these	   measurements	   are	   the	   260/280	   and	  
260/230	   ratios.	   Those	   are	   used	   to	   evaluate	   the	   purity	   of	   RNA	   or	   DNA.	   Concerning	   here	   RNA,	   the	  
solution	  is	  received	  as	  pure	  if	  the	  260/280	  ratio	  is	  around	  2.	  A	  lower	  number	  would	  indicate	  presence	  
of	  contaminants	  such	  as	  proteins	  or	  phenol	  absorbing	  light	  near	  280nm.	  	  The	  260/230	  ratio	  has	  to	  be	  
between	  1.8	  and	  2.2,	  and	  co-­‐purified	  contaminants	  would	  also	  lower	  this	  number.3	  
	  
RNA	  precipitation	  	  
After	  measurements	  with	  the	  NanoDrop,	  the	  samples	  were	  precipitated	  in	  order	  to	  remove	  
all	  contaminants.	  The	  following	  procedure	  was	  very	  helpful	  in	  removing	  all	  contaminants.	  Moreover,	  
the	  both	  ratios	  were	  then	  around	  2,	  indicating	  pure	  RNA	  samples.	  
	  The	  successive	  addition	  of	  3M	  NaOAc	  pH	  5.2,	  EtOH	  and	  glycogen	  with	  2	  hours	  at	   -­‐80°C	  for	  
precipitation	  was	  followed	  by	  30	  minutes	  of	  centrifugation,	  2	  washes	  with	  cold	  70%	  EtOH.	  The	  pellet	  
is	   air	   dried	   10	   min	   before	   to	   be	   resuspended	   and	   re-­‐concentrated	   in	   nuclease-­‐free	   H2O	   to	   yield	  
desired	  concentration.	  
	  
RNA	  quality	  control	  
	  After	   having	   performed	   the	   extraction	   and	   purification	   of	   the	   totRNA,	   the	   quality	   control	  
was	  made	  at	  the	  UNIL	  DAFL	  facility:	  they	  used	  the	  Agilent	  2100	  Bioanalyzer	  of	  Agilent	  Technologies.	  
Basically,	  the	  RNA	  6000	  Pico	  kit	  used	  with	  this	  technology	  takes	  the	  advantage	  of	  microscale	  
format	   to	   determine	   the	   quality	   of	   a	   sample.	   Moreover,	   only	   very	   small	   amount	   of	   samples	   are	  
required	  in	  order	  to	  perform	  the	  analysis.	  After	  the	  analysis,	  the	  bioanalyzer	  is	  able	  to	  represent	  the	  
data	  on	  an	  electropherogram,	  accompanied	  with	  a	  gel-­‐like	  image	  that	  facilitates	  the	  representation	  
of	   the	   samples’	   quality	   (Figure	   9).	   A	   good	   quality	   totRNA	   will	   be	   represented	   on	   the	  
electropherogram	  by	  two	  ribosomal	  peaks,	  the	  18S	  and	  28S	  and	  the	  ratio	  of	  28S/18S	  peaks	  should	  be	  
higher	   than	   2.	   In	   the	   case	   presented	   in	   Figure	   9,	   the	   totRNA	   presents	   some	   degraded	   RNA:	   the	  
additional	   peaks	   represents	   shorter	   RNA	   fragments	   that	   have	   the	   tendency	   to	   decrease	   the	   ratio	  







	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
3	  Nanodrop	  User	  Manual,	  p-­‐27-­‐30	  :	  http://www.nanodrop.com/Library/nd-­‐1000-­‐v3.7-­‐users-­‐manual-­‐8.5x11.pdf	  






Figure	  9:	  (A)	  Example	  of	  an	  electropherogram	  obtained	  from	  the	  bioanalyzer	  	  (B)	  Example	  of	  the	  
gel-­‐like	   image	   corresponding	   to	   the	   electropherogram.	   The	   18S	   and	   28S	   peaks	   represent	   the	  
ribosomal	  mRNA	  peaks,	  also	  present	  on	  the	  gel	  image:	  the	  two	  upper	  darker	  bands:	  at	  1.9	  kb	  for	  




The	  amount	  of	  RNA	  extracted	  from	  macrophages	  and	  LCM	  samples	  was	  quite	  low	  (between	  
150-­‐170	  ng)	  and	  the	  minimal	  amount	   required	   to	  perform	  microarrays	   is	  12,5	  μg.	   In	  order	   to	  have	  
enough	  material	   to	   perform	   both	   Affymetrix	  microarrays	   and	   qPCRs	   thereafter,	   it	   was	   decided	   to	  
amplify	  the	  starting	  material	  with	  the	  Ovation	  Pico	  WTA	  System	  from	  NuGen	  technologies.	  	  
The	   advantages	   are	   that	   the	   amplification	   is	   initiated	   both	   at	   the	   poly(A)	   tails	   but	   also	  
randomly	   throughout	   the	   whole	   transcriptome	   so	   that	   the	   coverage	   is	   complete4.	   This	   allows	  
analyzing	   both	   degraded	   or	   partially	   compromised	   RNA	   samples	   and	   non-­‐poly(A)	   transcripts.	   The	  
amplified	  product	  is	  also	  optimized	  for	  analysis	  on	  Affymetrix	  GeneChip	  arrays.	  	  
This	  system	  is	  based	  on	  the	  Ribo-­‐SPIA	  technology	  from	  NuGen,	  in	  which	  a	  rapid,	  simple	  and	  
sensitive	  RNA	  amplification	  is	  made	  following	  a	  three-­‐step	  process	  that	  generates	  amplified	  cDNA	  in	  
microgram	  quantities.	  In	  brief,	  the	  3	  steps	  are	  (Figure	  10):	  	  
1) The	  first	  step	  is	  the	  generation	  of	  the	  first	  strand	  cDNA:	  Reverse	  transcriptase	  and	  DNA/RNA	  
chimeric	  primer	  mix	  allows	   the	  3’	  DNA	  end	  of	  each	  primer	  generating	   first	   strand	  cDNA.	   It	  
results	  an	  mRNA/cDNA	  hybrid	  molecule	  containing	  a	  unique	  RNA	  sequence	  at	   the	  5’end	  of	  
the	  cDNA	  strand.	  	  
2) Then,	  the	  fragmentation	  of	  the	  mRNA	  within	  the	  hybrid	  molecule	  creates	  the	  priming	  sites	  so	  
that	   the	   DNA	   polymerase	   can	   elongate	   the	   second	   strand.	   The	   double	   strand	   cDNA	   is	  
generated,	  still	  containing	  a	  hybrid	  RNA/DNA	  end.	  
3) Finally,	   the	   SPIA	   amplification	   takes	   place:	   the	   DNA	   is	   amplified	   linearly	   and	   thus	   the	  
difference	   in	   their	   expression	   levels	   is	   maintained.	   In	   this	   reaction,	   successive	   steps	   are	  
repeated:	   SPIA	   DNA/RNA	   primer	   binding,	   DNA	   replication,	   strand	   displacement	   and	   RNA	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
4	  http://www.nugeninc.com/tasks/sites/nugen/assets/File/user_guides/userguide_pico_wta.pdf	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cleavage	  by	  an	  RNase.	  This	  lead	  to	  a	  rapid	  accumulation	  of	  cDNA:	  these	  molecules	  have	  the	  
complementary	  sequences	  to	  the	  original	  mRNA.	  	  
	  
	  
Figure	  10:	  The	  Ribo-­‐SPIA	  RNA	  Amplification	  Process	  used	  in	  the	  Ovation	  Pico	  WTA	  System5	  
	  
RNA	  fragmentation	  and	  labeling	  process	  
	  
To	   further	   hybridize	   samples	   to	  Affymetric	  GeneChip	  Arrays,	   the	   obtained	   cDNA	  has	   be	   to	  
fragmented	  and	  biotin	  labeled	  to	  generate	  targets	  that	  are	  suitable	  for	  arrays	  hybridization.	  	  
	   These	   steps,	   performed	   at	   the	   DAFL,	   were	   performed	   using	   the	   Nugen	   Encore™	   Biotin	  
Module6.	   The	   fragmentation	   combines	   a	   chemical	   and	   enzymatic	   process	   to	   generate	   a	   single-­‐
stranded	  cDNA	  in	  the	  50	  to	  100	  base	  range.	  	  In	  the	  next	  step,	  the	  obtained	  product	  gets	  labeled	  via	  
enzymatic	  attachment	  with	  a	  biotin-­‐labeled	  nucleotide	   to	   the	  3’	  end	  of	   the	   fragmented	  cDNA.	  The	  




	   The	   GeneChip	   Mouse	   Gene	   1.0	   ST	   Array	   (Affymetrix)	   was	   used	   to	   determine	   the	   gene	  
expression	  profile	  of	   the	  different	  samples.	   It	  offers	  whole-­‐transcript	  coverage	   in	  which	  the	  28’853	  
genes	   are	   represented	  by	   approximately	   27	   probes	   spread	   across	   the	   full	   length	  of	   the	   gene.	   This	  
provides	  a	  complete	  and	  accurate	  representation	  of	  gene	  expression7.	  	  




	   	   24	  
	  
	   After	  fragmentation	  process	  described	  above,	  the	  hybridization	  of	  the	  labeled	  samples	  could	  
take	   place.	   The	   microarrays	   were	   then	   washed	   and	   scanned	   to	   return	   an	   output	   file,	   a	   CEL	   file,	  
containing	   for	   each	   probeset	   a	   value	   representing	   the	   level	   of	   expression.	   From	   the	   CEL	   file,	   the	  
statistical	  analysis	  could	  be	  launched,	  with	  the	  help	  of	  our	  bioinformatician,	  Paolo	  Provero.	  	  
	  	  
Quantitative	  Real-­‐Time	  RT-­‐PCR	  	  
	  
Reverse	   transcription-­‐	   quantitative	   polymerase	   chain	   reaction,	   RT-­‐qPCR,	   represents	   a	   very	  
sensitive	  technique	  allowing	  the	  detection	  and	  quantification	  of	  mRNAs	  expression	  in	  a	  given	  sample.	  	  
First	  of	  all,	  mRNA	  is	  transcribed	  to	  cDNA	  using	  a	  reverse	  transcription	  reaction	  and	  this	  cDNA	  
is	   the	  template	  for	  the	  quantitative	  PCR	  realized	  thereafter.	  Only	  specific	  region	  of	  the	  target	  gene	  
gets	   amplified	   with	   this	   technique	   by	   the	   use	   of	   gene-­‐specific	   primers	   or	   probes	   fluorescently	  
labeled.	   The	   device	   monitors	   during	   the	   reaction	   the	   fluorescence	   emitted,	   a	   parameter	   that	   is	  
related	   to	   the	   amount	   of	   product	   for	   each	   tested	  mRNA	  of	   interest.	   Then,	   since	   one	   cycle	   can	   be	  
considered	  to	  double	  the	  number	  of	  molecules	  present	  in	  the	  solution,	  the	  user	  can	  then	  determine	  
the	   initial	   quantity	   of	   RNA	   in	   the	   samples,	   relatively	   to	   a	   control	  mRNA,	   allowing	   to	   establish	   the	  
expression	  level	  of	  a	  given	  gene	  in	  the	  present	  sample	  [18].	  
	   Practically,	   after	   mRNA	   extraction,	   500ng	   of	   mRNA	   is	   taken	   for	   a	   reaction	   of	   reverse	  
transcription	   in	   order	   to	   obtain	   corresponding	   cDNA.	   Random	   hexamers,	   dNTPs	   and	   reverse	  
transcriptase	  were	  mixed	  following	  standard	  method	  with	  the	  template	  mRNA.	  Thereafter,	  the	  real-­‐
time	  PCR	  could	  be	  performed	  using	  the	  ABI	  Prism	  7700	  device	  from	  Applied	  Biosystems.	  SyBR	  green	  
mix	  and	  TaqMan	  primers	  and	  probes	  where	  used	   for	   the	  quantification	  reaction.	  To	  explain	  briefly	  
the	  mode	  of	  action	  of	  both,	  first	  the	  SyBR	  green	  is	  a	  double-­‐stranded	  DNA	  intercalant.	  Thus	  it	  binds	  
to	  the	  PCR	  product	  obtained	  after	  the	  step	  of	  amplification.	  As	  the	  amount	  of	  PCR	  product	  increase,	  
the	   amount	   of	   bound	   SyBR	   green	   increases	   also.	   For	   the	   Taqman	   probes,	   the	   mode	   of	   action	   is	  
slightly	  different:	  the	  probe	  contains	  at	  its	  3’end	  a	  quencher	  dye	  and	  at	  the	  5’	  end	  a	  reporter	  dye.	  In	  
the	   unbound	   state,	   no	   fluorescence	   is	   emitted	   since	   the	   proximity	   of	   both	   allows	   the	   3’	   end	   to	  
quench	  the	  reporter.	  The	  5’	  nuclease	  activity	   is	  exploited	  during	  the	  PCR	  reaction:	   it	  will	  cleave	  the	  
probe	  so	  that	  reporter	  and	  quencher	  are	  separated	  and	  thus,	  fluorescence	  is	  now	  emitted.	  For	  every	  
cell	   type	  an	  endogenous	  control	  mRNA	  was	   tested	   in	  order	   to	  normalize	   the	   level	  of	  expression	  of	  
the	  other	  tested	  mRNAs.	  	  
	   Concerning	  the	  PCR	  cycles	  set	  up,	  these	  are	  the	  following:	  
	   Temperature	  	   Time	  
Stage	  1	  	   50°	  C	   2	  min	  
Stage	  2	  	  
Denaturation	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   The	  sequences	  of	  the	  forward	  (Fw)	  and	  reverse	  (Rev)	  primers	  and	  probes	  are:	  
	   mIL1b-­‐FW	   :	  5’-­‐TGC	  AGA	  GTT	  CCC	  CAA	  CTG	  GT	  -­‐3’	  
	   mIL1b-­‐RV	   :	  5’-­‐	  CCA	  TCA	  GAG	  GCA	  AGG	  AGG	  AA-­‐3’	  
	   mIL-­‐1R1	  FW	   :	  5’-­‐	  CTG	  TAA	  ACC	  TCT	  GCT	  TCT	  TGA	  C-­‐3’	  
	   mIL-­‐1R1	  RV	   :	  5’-­‐	  TGG	  TTG	  AAG	  GAT	  GTT	  CCA	  CA-­‐3’	  
	   mIL18	  FW	   :	  5’-­‐GGC	  CGA	  CTT	  CAC	  TGT	  ACA	  ACC	  GC-­‐3’	  
	   mIL18	  RV	  	   :	  5’-­‐ACA	  GAG	  AGG	  GTC	  ACA	  GCC	  AGT	  CC-­‐3’	  
	   mCasp1	  FW	   :	  5’-­‐AAG	  GCA	  CGG	  GAC	  CTA	  TGT	  GA-­‐3’	  
	   mCasp1	  RV	   :	  5’-­‐AGC	  TCC	  AAC	  CCT	  CGG	  AGA	  AA-­‐3’	  
	   mBeta	  Actin	  FW	   :	  5’-­‐	  ATGGATGACGATATCGCTGCGCTGGTCGTC-­‐	  3’	  
	   mBeta	  Actin	  RV	   :	  5’-­‐	  CTA	  GAA	  GCA	  CTT	  GCG	  GTG	  CAC	  GAT	  GGA	  GGG-­‐	  3’	  
	  	   mGAPDH	  FW	   :	  	  5’-­‐	  ACCACCAACTGCTTAGCCCCCCTGGCCAA-­‐3’	  
	   mGAPDH	  FW	   :	  	  5’-­‐	  GGA	  TGC	  AGG	  GAT	  GAT	  GTT	  CTG	  GGC	  AGC	  CCC	  AC	  -­‐3’	  	  
	  	  
	   For	   the	   NALP3	   probe,	   the	   sequence	   is	   unknown	   since	   AB	   is	   selling	   it	   ready	   to	   use	   and	  
specifically	  for	  NALP3,	  see	  the	  reference8.	  The	  same	  stands	  for	  the	  miRNAs	  primers	  sequences	  that	  
were	  ordered	  on	  the	  Exiqon	  platform	  for	  the	  following	  miRNAs:	  miR-­‐21,	  miR-­‐140,	  miR-­‐155,	  miR-­‐181,	  




This	   technique	   allows	   specific	   identification	   of	   proteins	   by	   the	   use	   of	   corresponding	  
antibodies.	  Basically,	  the	  proteins	  are	  separated	  according	  to	  their	  size	  through	  gel	  electrophoresis.	  
The	  gel	  is	  then	  put	  in	  contact	  with	  a	  membrane	  made	  of	  nitrocellulose.	  Thanks	  an	  electrical	  current	  
applied	  to	  the	  assembly,	  the	  proteins	  contained	  in	  the	  gel	  are	  transferred	  to	  the	  membrane	  so	  that	  
the	  latter	  becomes	  a	  replicate	  of	  the	  gel’s	  pattern.	  This	  membrane	  can	  then	  be	  stained	  with	  Ponceau	  
Red	  to	  detect	  the	  presence	  of	  proteins	  and	  then	  it	  is	  blocked	  with	  milk	  so	  that	  the	  specific	  antibodies	  
can	  be	  applied	  to	  target	  accurately	  the	  protein	  of	   interest.	  This	  can	  then	  be	  detected	  using	  specific	  
development	  methods.	  	  
	  
Practically	  the	  method	  is	  as	  follows:	  
1. The	  proteins	  are	  extracted	  using	  a	  specific	  lysis	  buffer.	  The	  supernatant	  of	  cell	  culture	  can	  
also	   be	   used.	   In	   our	   case,	   the	   lysis	   buffer	   used	   is	   composed	   of:	   50mM	  Tris	   HCl	   pH7.4,	  
150mM	   NaCl,	   1mM	   EDTA,	   1%	   Triton	   X-­‐100	   and	   proteases	   inhibitors.	   The	   dosage	   of	  
proteins	   is	   then	  made	  using	   the	   standard	  Bradford	  method	   (Bio-­‐Rad	  Protein	  Assay).	  To	  
determine	  the	  correct	  concentration	  of	  proteins,	  a	  reference	  range	  is	  made	  using	  BSA.	  
2. The	  proteins	  extracts	  are	  then	  denaturated	  5	  minutes	  at	  100°C	  in	  the	  loading	  buffer.	  This	  
buffer	  is	  composed	  of:	  10mM	  Tris,	  6,9%	  SDS,	  15%	  β-­‐mercaptoethanol,	  30%	  glycerol,	  5%	  
bromophenol	  blue.	  
3. The	  gel	  electrophoresis	  can	  then	  be	  run.	  The	  gel	   is	  composed	  of	   two	  stacks:	  at	  bottom	  
the	  running	  gel	  allows	  separating	  proteins	  according	  to	  their	  size	  and	  above	  the	  stacking	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gel	  provide	  an	  environment	  concentrating	  the	  proteins,	  creating	  a	  thin	  starting	  zone.	  The	  
composition	  of	  gels	  is	  standard.	  	  
4. After	   the	   electrophoresis,	   the	   gel	   is	   taken	   out	   and	   put	   in	   contact	  with	   a	   nitrocellulose	  
membrane	   so	   that	   the	   transfer	   of	   proteins	   contained	   in	   the	   gel	   to	   the	  membrane	   can	  
occur.	  	  
5. After	  2	  hours	  of	  transfer,	  the	  membrane	  is	  recovered	  and	  rinsed	  with	  TBS	  solution.	  Red	  
Ponceau	   is	   put	   then	   to	   color	   basically	   all	   the	   proteins	   present	   on	   the	  membrane.	   This	  
color	  is	  washed	  several	  times	  with	  TBS	  and	  then	  the	  blocking	  of	  aspecific	  sites	  is	  realized	  
with	   a	   solution	   containing	   5%	   Regilait,	   10%	   TBS	   and	   0.1%	   Tween-­‐20.	   3	   washes	   are	  
necessary	   before	   to	   put	   the	   primary	   antibody	   overnight.	   For	   the	   exact	   dilutions	   of	  
antibodies	   used,	   see	   the	   following	   table.	   Again,	   3	  washes	   are	  made	   before	   to	   put	   the	  
anti-­‐α-­‐tubulin	   antibody	   for	   1	   hour.	   After	   washes,	   the	  membrane	   is	   incubated	   1	   hours	  
with	  a	  mix	  of	  secondary	  antibodies	  that	  are	  Horse-­‐Radish-­‐Peroxidase	  (HRP)-­‐conjugated.	  
6. The	   final	   step	   is	   the	   rinsing	   and	   the	   revelation	   is	   made	   by	   chemiluminescence.	   The	  
substrate	   of	   the	   HRP	   is	   added	   on	   the	   membrane	   and	   incubated	   according	   to	   the	  
manufacturers’	   instructions10.	   The	   SuperSignal	  West	   Pico	   and	   Femto	   kits	   from	   Thermo	  
Scientific	  were	  used.	  Then,	  the	  blots	  are	  exposed	  to	  film	  for	  30	  seconds	  or	  one	  minutes	  
exposures,	  depending	  on	  the	  signal	  obtained.	  	  
	  
The	  antibodies	  used	  were	  as	  follows:	  
Antibody	   	   Dilution	  used	  
Rabbit	  anti-­‐IL-­‐1β	   Abcam	   1/3’000	  
Mouse	  anti-­‐α-­‐tubulin	   Abcam	   1/4’000	  
Rat	  anti-­‐IL-­‐1R1	  	   R&D	  Systems	   1/500	  
Anti-­‐mouse	  antibody	  HRP-­‐conj.	   Dako	   1/20’000	  
Anti-­‐rabbit	  antibody	  	  HRP-­‐conj.	   Dako	   1/10’000	  &	  1/20’000	  
	  
	  
	  CLONING	  STRATEGY	  
Silencing	  and	  overexpression	  of	  the	  Interleukin	  1	  Receptor	  type	  I	  -­‐	  	  Il-­‐1R1	  	  
In	  order	  to	  study	  the	   importance	  on	  metastasis	  capability	  of	   the	   IL1-­‐RI,	  overexpression	  and	  
silencing	  of	  this	  receptor	  on	  the	  surface	  of	  the	  cells	  of	  interest	  was	  to	  be	  studied.	  We	  had	  to	  design	  a	  
specific	  protocol	   for	  each	  cloning	  strategy,	   since	   it	   involves	   in	  vitro	  preliminary	   tests	  and	   further	   in	  
vivo	  studies.	  	  
SILENCING	  
Since	  the	  silencing	  should	  also	  be	  efficient	  for	  further	  in	  vivo	  studies,	  it	  was	  decided	  to	  use	  a	  
small	  hairpin	  RNA,	  shRNA,	  therefore	  inducing	  a	  stable	  and	  long-­‐term	  silencing	  of	  the	  target	  mRNA.	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   Stable	  transfection	  
This	  kind	  of	  RNA,	  designed	  as	  a	  tight	  hairpin	  turn,	  works	  via	  RNA	  interference:	  it	  uses	  a	  vector	  
that	  gets	  introduced	  into	  the	  genome	  of	  cells.	  The	  shRNA	  is	  under	  the	  regulation	  of	  the	  U6	  promoter	  
that	  will	  ensure	  its	  expression	  to	  be	  constitutive	  in	  the	  target	  cells.	  	  
	  
The	   shRNA	   is	   processed	   by	   the	   cellular	   machinery	   so	   that	   it	   can	   bind	   the	   RNA-­‐induced	  
silencing	   complex,	   RISC.	   The	   cleavage	   of	   the	   target	   mRNA	   is	   then	   made	   by	   the	   complex	   of	   both	  
molecules,	  leading	  to	  proteasomal	  degradation	  or	  translational	  repression.	  	  
Technically,	  the	  RNAi-­‐Ready	  pSIREN	  was	  used	  as	  a	  vector,	  in	  which	  we	  introduced	  the	  shRNA	  
targeting	   the	   Il1R1.	   The	   selection	   of	   the	   target	   sequences	   is	   very	   important	   in	   order	   to	   correctly	  
match	  the	  mRNA	  of	  interest	  and	  be	  efficient	  in	  the	  repression.	  Different	  criteria	  have	  to	  be	  fulfilled	  
during	  the	  selection	  and	  at	  least	  2	  shRNAs	  per	  gene	  have	  been	  designed,	  since	  most	  of	  the	  time,	  one	  
of	   them	  works	  better	   than	  the	  other	  one	  and	  also	   to	  be	  sure	   that	   the	  observed	  changes	  are	  really	  
due	  to	  the	  sh	  and	  not	  to	  an	  artifact.	  Moreover,	  a	  control	  sh	  molecule	  is	  required:	  this	  one	  is	  designed	  
so	  that	  it	  is	  a	  scramble	  of	  the	  “active”	  sh,	  meaning	  that	  it	  should	  not	  bind	  at	  any	  region	  of	  the	  gene.	  It	  
is	  required	  so	  that	  the	  cells	  of	  interest	  also	  undergo	  the	  same	  protocol	  and	  selection	  procedures	  as	  
the	  one	  with	  the	  active	  sh.	  	  
	  
The	  sequences	  taken	  for	  the	  silencing	  and	  introduced	  in	  the	  pSIREN	  vector	  are	  the	  following:	  	  
-­‐	  mIL-­‐1RI	  shRNA	  762	  :	  Top	  Strand	  (66bp)	  	  
5'-­‐gatccGCGGTCACACGAGTAATACATTCAAGAGATGTATTACTCGTGTGACCGTTTTTTACGCGTg-­‐-­‐-­‐-­‐-­‐3'	  
-­‐	  mIL-­‐1RI	  shRNA	  916	  :	  Top	  Strand	  (66bp)	  	  
5'-­‐gatccGCTGGAAGTGGAATGGATCATTCAAGAGATGATCCATTCCACTTCCAGTTTTTTACGCGTg-­‐-­‐-­‐-­‐-­‐3'	  
-­‐mIL-­‐1R1	  shRNA	  shCTL:	  scramble	  molecule:	  Top	  Strand	  (66bp)	  
5'-­‐gatccGGTTTAGGGTCATTCTATAGTTCAAGAGACGCTTGTATCGTTGTAATAGTTTTTTACGCGTg-­‐-­‐-­‐-­‐-­‐	  3'	  
	  
Beside	   the	   shIl1R1	   that	   targets	   the	  most	   efficiently	   the	  mRNA	  encoding	   the	   Il-­‐1R1	  protein,	  
sh762,	  the	  sh916	  was	  less	  efficient	  but	  we	  used	  it	  in	  all	  the	  experiment	  made.	  The	  control-­‐scramble	  
sh	  is	  called	  in	  the	  rest	  of	  the	  report	  as	  the	  shCTL.	  	  
	  
	  
Figure	  11:	  Schematic	  representation	  of	  shRNA	  11	  
	  
The	  procedure	  to	  obtain	  tumor	  cells	  transfected	  with	  the	  shIl1R1	  is	  then	  the	  following	  (Figure	  12):	  
-­‐	   The	   first	   step	  was	   to	   ligate	   the	   annealed	   double-­‐stranded	   oligonucleotide	   into	   the	   RNAi-­‐
Ready	  pSIREN,	  the	   latter	  being	  previously	  digested	  with	  BamHI	  and	  EcoRI	   in	  order	  to	  get	  an	  empty	  
vector,	  ready	  to	  welcome	  a	  new	  sequence.	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
11	  http://www.clontech.com/images/pt/dis_manuals/PT4055-­‐1.pdf	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-­‐	   The	   next	   step	   is	   to	   transfect	   bacteria	   (E.coli	   DH10)	   by	   electroporation,	   so	   that	   we	   could	  
select	   those	  bacteria	  being	  positive	   for	   the	  plasmid	   thanks	   the	  ampicillin	   resistance	   the	   introduced	  
vector	  confers.	  	  
-­‐	  Different	  steps	  are	  then	  required	  to	  verify	  that	  the	  RNAi	  sequences	  are	  really	  in	  the	  plasmid:	  
miniprep	  for	  recuperation	  of	  the	  plasmid,	  digestion	  with	  MluI	  and	  electrophoresis	  migration	  in	  order	  
to	   check	   the	   right	   linearization	   of	   the	   plasmid	   and	   finally	   sequencing	   reaction.	   If	   the	   sequence	   is	  
correct	  and	  the	  vector	  contains	  the	  desired	  sh,	   the	  plasmid	  gets	  amplified	  via	  bacterial	  culture	  and	  
gets	  extracted	  with	  a	  maxiprep.	  	  
-­‐	  GP2	  cells	  are	  then	  used	  because	  of	  their	  ability	  to	  produce	  retroviruses.	  By	  mixing	  a	  given	  
plasmid	   encoding	   for	   the	   envelope	   of	   the	   VSV	   virus,	   the	   plasmid	   of	   interest,	   pSIREN	   containing	  
shIl1R1,	  and	  FuGENE,	  a	  reagent	  that	  helps	  to	  cross	  cell	  membrane,	  we	  get	  micelles	  that	  are	  ready	  to	  
enter	  the	  GP2	  cells.	  After	   incubation,	  GP2	  produce	  enough	  viruses	   in	  the	  supernatant.	  The	   latter	   is	  
filtered	  and	  used	  to	  do	  two	  rounds	  of	  infections	  on	  the	  cells	  of	  interest,	  in	  our	  case:	  B16-­‐F10	  and	  LLC-­‐
B6	  tumor	  cells.	  	  
-­‐	  The	  final	  step	  is	  then	  to	  select	  the	  cells	  having	  correctly	  integrated	  the	  virus	  and	  thus	  the	  sh	  
of	  interest	  with	  at	  least	  4	  rounds	  of	  selection	  with	  the	  drug-­‐resistance	  marker	  included	  in	  the	  




The	   overexpression	   of	   the	   Il1r1	   gene	   was	   carried	   out	   using	   the	   pMM34	   plasmid.	   In	   this	  
plasmid,	  the	  promoter	  sitting	  in	  front	  of	  the	  introduced	  target	  gene	  is	  also	  expressed	  constitutively.	  	  
The	  first	  step	  of	  the	  procedure	  was	  to	  isolate	  a	  template	  from	  a	  given	  library	  of	  murine	  cells:	  
taking	  primers	  on	  the	  mRNA	  of	  the	  transcript	  variant	  1	  of	  Il1R1,	  we	  could	  isolate	  the	  mRNA	  sequence	  
of	   Il1R1	  of	  1962	  bp	   in	  order	  to	  clone	   it	   into	  the	  pMM34	  vector.	  The	  primers	  used	  to	  do	  so	  are	  the	  
following:	  	  
For	  the	  forward	  primer,	  it	  has	  to	  introduce	  the	  restriction	  site	  for	  further	  cloning	  in	  pMM34,	  
the	  PmeI	  site	  (in	  blue):	  
	   Primer	  Forward	  1:	  	  
5’	  –	  ACGTTTAAACTGAGCTGTCTGTCATTCTTG–	  3’	  
	   PmeI	   	   	   Fw	  
 
Concerning	  the	  reverse	  primers,	   two	  primers	  were	  used	  so	  that,	  beside	  the	   introduction	  of	  
the	   second	   restriction	   site	   required	   for	   cloning	   into	   pMM34,	   a	   V5	   tag	   was	   introduced,	   allowing	  
further	  specific	  protein	  isolations.	  Two	  steps	  of	  amplifications	  were	  thus	  required	  to	  introduce	  both:	  	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Primer	  Reverse	  1:	  	  
5’	  –	  CGCGTAGAATCGAGACCGAGGAGAGGGTTAGGGATAGGCTTACCGCCGAGTGGTAAGTGTGT-­‐	  3’	  
	   	   	   v5	  Part1	  	   	   	   	   	   	  	  	  	  	  	  	  	  Rv	  	  
Primer	  Reverse	  2:	  	  
5’	  -­‐	  TATCATATGTCAATGGTGATGGTGATGATGACCGGTACGCGTAGAATCGAGACCGAGGAG	  -­‐	  3’	  
	  	  	  	  	  	  	  	  	  	  	  NdeI	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  v5	  Part2	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In	  the	  design	  of	  the	  plasmid,	  the	  mRNA	  sequence	  of	  the	  Il1R1	  was	  taken	  since	  we	  only	  need	  
this	  sequence	  to	  get	  the	  protein	  expressed.	  Since	  the	  mRNA	  sequence	  is	  shorter	  than	  the	  gene	  itself,	  
it	  renders	  the	  cloning	  easier.	  	  
Moreover,	   concerning	   the	  drug-­‐markers	  used,	   it	  was	   interesting	   to	  use	  2	  different	  pMM34	  
plasmids:	  one,	  pLIV	  puro,	  contains	  the	  puromycin	  resistance	  cassette	  and	  the	  other	  one,	  pLIV	  hygro,	  
contains	  hygromycin	  resistance	  gene.	  The	  reason	  is	  because	  of	  the	  target	  tumor	  cells:	  the	  B16-­‐	  F10	  
cells	  were	  also	  previously	  modified	  so	  that	  they	  express	   luciferase	  and	  this	  cloning	  was	  made	  using	  
the	   puromycin	   resistance	   gene,	   so	   that,	   on	   these	   cells,	   another	   infection	  with	   the	   same	   antibiotic	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selection	  would	  not	  be	  representative.	  Thus,	  having	  a	  second	  selection	  cassette	  for	  the	  introduction	  
of	   the	   overexpression	   allows	   the	   B16-­‐F10	   luciferase-­‐expressing	   cells	   to	   be	   infected	   with	   the	  
overexpression	  plasmid,	  for	  an	  eventual	  in	  vivo	  experiment.	  
	  
This	   sequence	   was	   then	   amplified	   using	   the	   high-­‐fidelity	   polymerase	   Phusion	   Hot	   Start	  
Enzyme,	   The	   PCR	   required	   2	   steps,	   one	  with	   the	   forward	   primer	   and	   the	   reverse	   1,	   one	  with	   the	  
same	   forward	   primer	   and	   the	   second	   reverse	   one.	   Different	   set-­‐ups	   were	   necessary	   in	   order	   to	  
correctly	  isolate	  the	  mRNA	  of	  interest.	  After	  verification	  and	  purification	  of	  the	  right	  sequence	  with	  
gel	  electrophoresis,	  the	  digestion	  of	  the	  PCR	  product	  and	  the	  pMM34	  receiver	  plasmid	  was	  realized	  
with	   PmeI	   and	   NdeI.	   Both	   products	   were	   isolated	   on	   a	   1%	   agarose	   gel	   and	   purified	   so	   that	   the	  
ligation	  could	  then	  take	  place.	  	  
The	  rest	  of	  the	  procedure	  basically	  remains	  the	  same	  as	  for	  the	  silencing:	  electroporation	  in	  
electrocompetent	   bacteria,	   selection,	   amplification	   and	   extraction	   of	   the	   plasmid	   of	   interest,	  
followed	  by	  transfection	  thanks	  retrovirus	  in	  GP2	  cells	  and	  finally	  infection	  of	  target	  cells.	  	  
Finally,	  the	  whole	  sequence	  on	  the	  plasmid	  was	  sequenced	  in	  order	  to	  check	  for	  mutation	  during	  the	  
cloning	  process.	  Here	  the	  primers	  used	  cover	  the	  whole	  sequence.	  These	  were	  designed	  using	  Clone	  
Manager	  and	  are	  the	  following:	  	  
	  
Forward	   Reverse	  
FWD	  1:	  	  5’-­‐TTTGTCTCATGGTGCCTCTG-­‐3’	  
FWD	  2:	  	  5’-­‐CCGAGGTCCAGTGGTATAAG-­‐3’	  
FWD	  3	  :	  5’-­‐TTGAGTCGGCGCATGTGCAG-­‐3’	  
FWD	  4:	  5’-­‐TGGGCCAGTCATCTGAAGAG-­‐3’	  
FWD	  5:	  5’-­‐CCGGTCATCATCACCATCAC-­‐3’	  	  
	  
REV	  3:	  	  5’-­‐GGGCCAGTTCTCAGACCTTG-­‐3’	  
REV	  4:	  5’-­‐TGGAGGGACAGTTTGGATAC-­‐3’	  
REV	  5:	  	  5’-­‐TACCGGTCATCATCACCATC-­‐3’	  
	  
Proliferation	  Assay	  	  
	  
Proliferation	  is	  an	  important	  factor	  to	  assess	  when	  a	  genetic	  modification	  is	   introduced	  in	  a	  
cell,	  to	  see	  the	  influence	  on	  survival	  and	  proliferation	  it	  can	  induce.	  
In	  this	  case,	  the	  Cell	  Titer	  96®	  Assay	  was	  used.	  The	  assay	  is	  based	  on	  the	  cellular	  reduction	  of	  
yellow	  MTT,	  a	  tetrazole,	  into	  purple	  formazan,	  a	  reaction	  taking	  place	  in	  mitochondria	  of	  living	  cells.	  
The	  advantage	  is	  that	  the	  absorbance	  of	  the	  colored	  solution	  is	  easily	  quantified	  by	  measuring	  it	  at	  a	  
given	  wavelength,	  usually	  between	  500	  and	  600	  nm,	  by	  a	  spectrophotometer.	  The	   idea	   is	   that	   this	  
reaction	  occurs	  only	  when	  mitochondrial	  reductase	  enzymes	  are	  active.	  Therefore,	  the	  conversion	  is	  
directly	  proportional	  to	  the	  number	  of	  viable	  and	  living	  cells13.	  The	  drawbacks	  of	  this	  technique	  are	  
the	  followings:	  first,	  the	  physiological	  state	  of	  cells	  can	  influence	  the	  enzymatic	  activities,	  and	  second	  
there	  can	  be	  differences	  in	  mitochondrial	  dehydrogenase	  activity	  with	  different	  cell	  types.	  	  
Practically,	   same	   amount	   of	   cells	   are	   plated	   (5000	   cells	   in	   a	   96	   well	   plate),	   including	   the	  
appropriate	  controls.	  After	  24h	  of	  incubation,	  the	  Dye	  Solution	  is	  added	  to	  the	  medium	  for	  4	  hours.	  
During	  this	  time,	  the	  living	  and	  metabolically	  active	  cells	  convert	  the	  tetrazolium	  component	  of	  the	  
dye	   solution	   into	   formazan.	   Then,	   a	   stop	   solution	   allowed	   solubilizing	   the	   formazan	   product:	   the	  
more	  the	  formazan	  product,	  the	  more	  the	  cells	  are	  metabolically	  active,	  the	  more	  the	  proliferation.	  
The	  absorbance	  at	  580nm	   is	   read	  using	  a	  plate	   reader.	  Proliferation	   levels	  can	   then	  be	  established	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
13	  http://www.mnstate.edu/provost/mtt%20proliferation%20assay%20protocol.pdf	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and	  compared	  between	  the	  different	  sets	  of	  cells,	  subtracting	  the	  average	  absorbance	  of	  the	  no-­‐cell	  
control	  wells.	  	  
	  
Migration	  Assay	  –	  Wound	  Assay	  
	  
This	   assay	   is	   carried	   out	   to	   estimate	   the	  migration	   rates	   of	   the	   different	   cells	   used	   and/or	  
different	   conditions	   introduced.	   Concerning	   cancer	   cells,	   it	   is	   a	   very	   interesting	   parameter	   to	  
determine	  since	  wound	  healing	  involves	  complex	  series	  of	  events	  that	  most	  tumor	  cells	  are	  able	  to	  
control.	  Provoking	  a	  wound	   in	  tissue	  culture	  can	  re-­‐activate	  some	  cascade	  that	  are	   important	   for	  a	  
given	  cell	  type	  in	  order	  to	  increase	  proliferation	  or	  extracellular	  matrix	  deposition14.	  	  
Basically,	  using	  a	   confluent	   cell	  monolayer,	   a	   small	   area	  gets	  disrupted	  by	   scratching	  a	   line	  
through	  the	  layer.	  This	  gap	  is	  then	  followed	  microscopically	  and	  the	  migration,	  if	  it	  happens,	  can	  be	  
inspected.	  This	  “healing”	  can	  be	  rapid,	  over	  several	  hours	  as	  well	  as	  taking	  few	  days,	  depending	  on	  
the	  cell	  type	  but	  also	  conditions	  of	  culture	  and	  the	  extend	  of	  the	  scratched	  region.	  	  
	   Practically,	  cells	  are	  cultured	  in	  48-­‐wells	  plate	  and,	  at	  confluence,	  the	  wound	  is	  realized	  with	  
a	   tip	  under	   the	  hood.	  The	  movement	  has	   to	  be	  precise	  and	  straight.	  Then,	   the	  dead	  and	  detached	  
cells	   are	   rinsed	  with	   2	   washes	  with	   PBS	   and	   then	   the	   normal	   culture	  medium	   is	   added.	   Every	   24	  
hours	   a	   picture	   is	   taken,	   making	   a	   mark	   on	   the	   cap	   of	   the	   plate	   to	   stay	   every	   time	   at	   the	   same	  
position.	  Such	  pictures	  are	  taken	  at	  a	  magnification	  of	  10x,	  but	  taking	  some	  at	  20x	  magnification	  can	  
be	  very	   interesting	   in	  terms	  of	  morphology.	  The	   latter	  point	  at	   the	   leading	  and	  trailing	  edge	  of	   the	  
cell	  can	  show	  different	  parameters	  of	  cell	  migration.	  	  
Soft	  Agar	  for	  Colony	  Formation	  Assay	  	  
	  
This	   assay	   allows	   measuring	   the	   invasion	   potential	   and	   properties	   of	   the	   cells	   to	   form	  
colonies	  in	  a	  three	  dimensional	  culture.	  The	  aggressiveness	  of	  tumor	  cells	  is	  closely	  linked	  to	  certain	  
phenotypical	  changes	  such	  as	  loss	  of	  polarity,	  loss	  of	  contact	  inhibition	  where	  cells	  can	  grow	  over	  one	  
another,	   and	   anchorage	   independence	   where	   cells	   form	   colonies	   in	   soft	   agar.	   Transformed	   cells	  
acquired	  the	  anchorage-­‐independent	  features,	  characteristic	  of	  tumor	  cells,	  so	  get	  the	  ability	  to	  grow	  
in	  a	  viscous	  gel	  without	  basement	  membrane	  as	  support.	  The	  colony	  formation	  assay	  is	  based	  on	  the	  
process	   by	  which	   these	   phenotypic	   differences	   can	   occur,	  mainly	   related	   to	   the	   process	   of	   in	   vivo	  
carcinogenesis15.	  	  
	   Practically,	   after	   having	   prepared	   the	   0.8%	   soft	   agar	   base	   layer,	   the	   cells	   are	   mixed	   with	  
medium	  and	  0.7%	  agar	  to	  form	  a	  top	  layer.	  A	  same	  number	  of	  cells	  are	  prepared	  and	  each	  cell	  type	  is	  
plated	  in	  triplicate.	  	  The	  assay	  is	  then	  realized	  over	  15-­‐20	  days	  to	  test	  the	  anchorage	  independency	  in	  
growth	  of	  the	  tested	  cells.	  Pictures	  are	  also	  taken	  every	  day,	  also	  using	  a	  mark	  on	  the	  cap	  of	  the	  plate	  
to	   stay	   at	   the	   same	   position	   for	   each	   picture.	   Finally,	   the	   morphology	   of	   the	   formed	   colonies,	   if	  
occurred,	  can	  be	  analyzed	  using	  cell	  stain	  and	  the	  number	  of	  colonies	  can	  be	  quantified.	  	  
	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
14	  http://www.mnstate.edu/provost/woundAssayProtocol.pdf	  
15	  http://www.mnstate.edu/provost/Soft%20Agar%20Assay%20Protocol.pdf	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IN	  VIVO	  STUDIES	  
	  
Tumor	  growth	  and	  metastasis	  assays	  
	  
Different	  types	  of	  cells	  were	  chosen	  for	  these	  assays:	  both	  types	  of	  tumor	  cells	  with	  down-­‐	  
and	   up-­‐regulated	   IL-­‐1R1	   were	   taken,	   adding	   cells	   with	   a	   control	   (CTL).	   Cells	   were	   detached	   from	  
culture	  plates	  with	  addition	  of	  2ml	  Trypsin-­‐EDTA,	  centrifuged	  and	  resuspended	  in	  a	  given	  quantity	  of	  
medium	  so	  that	  50’000	  cells	  could	  be	   injected	  subcutaneously	   in	  50ul	  for	  each	  mouse	  and	  500’000	  
cells	  for	  the	  tail-­‐vein	  injections,	  in	  150ul.	  C57BL/6	  male	  mice	  of	  8	  weeks	  were	  used	  for	  this	  purpose.	  	  	  
	  
 For	  subcutaneous	   injections	   (primary	  tumor	  growth	  assay),	  6	  mice	  were	  used	  with	  the	  
following	  scheme:	  	  
Mice	   were	   sacrificed	   2	   weeks	   after	   injection,	   tumors	   were	   removed,	   weighted	   and	  
measured,	  and	  included	  in	  paraffin	  for	  later	  morphologic	  and	  infiltration	  observations.	  
	  
LEFT	  (on	  the	  back)	  	   RIGHT	  (on	  the	  back)	  	  
B16-­‐F10	  CTL	   B16-­‐	  F10	  sh762	  
B16-­‐F10	  CTL	   B16-­‐F10	  sh762	  
LLC-­‐B6	  CTL	   LLC-­‐B6	  sh762	  
LLC-­‐B6	  CTL	   LLC-­‐B6	  sh762	  
B16-­‐F10	  overexpressing	  IL-­‐1R1	   LLC-­‐B6	  overexpressing	  IL-­‐1R1	  
B16-­‐F10	  overexpressing	  IL-­‐1R1	   LLC-­‐B6	  overexpressing	  IL-­‐1R1	  
	  
 For	  tail-­‐vein	  injections	  (experimental	  metastasis	  assay),	  2	  mice	  were	  taken	  for	  each	  cell	  
types,	  i.e.,	  B16-­‐F10	  and	  LLC-­‐B6	  and	  for	  both:	  sh762,	  overexpression	  of	  IL-­‐1R1	  and	  CTL.	  :	  	  
Mice	  were	   sacrificed	   2	  weeks	   after	   injection,	   lungs	   and	   livers	  were	   carefully	   removed,	  
visible	  metastatic	   foci	  were	   counted	  before	   to	   include	   these	   organs	   in	   paraffin.	  Micro-­‐
metastases	  were	   then	  counted	  by	  microscopy	  and	   the	  percentage	  of	   lung/liver	   surface	  
colonized	  with	  metastasis	  was	  evaluated.	  Criteria	  for	  identification	  of	  metastases:	  	  
-­‐ Round	  shape	  
-­‐ Uniformly	  colored	  
-­‐ Appearance	  different	  from	  surrounding	  normal	  tissue	  
	  	  
Xenogen	  Bioluminescent	  System	  	  
	  
After	   the	   tail	   vein	   injection	   of	   tumor	   cells,	   it	   is	   possible	   to	   monitor	   in	   vivo	   growth	   of	  
metastases	  with	   a	   non-­‐invasive	   bioluminescent	  measuring	   device,	   using	   the	   Xenogen	   IVIS	   System.	  
This	  device	  quantifies	  single-­‐photon	  signals	  originating	  within	  the	  tissue	  of	  living	  mice,	  thanks	  to	  the	  
luciferase	  gene	  previously	  introduced	  in	  tumor	  cells	  genome.	  	  
Briefly,	   this	   enzyme	   oxidizes	   its	   substrate,	   the	   luciferin,	   to	   produce	   an	   oxidized	   substrate,	  
oxyluciferin,	  and	  energy	  in	  form	  of	  light,	  responsible	  for	  photon	  emission.	  The	  minor	  disadvantage	  is	  
that	  the	   luciferin	  has	  to	  be	   intraperitoneously	   injected	  just	  before	  each	  imaging	  session.	  Moreover,	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from	  that	  point,	   the	  maximum	  photon	  emission	  signal	   is	   reached	  during	   the	   first	  10-­‐12	  minutes	  so	  
that	  the	  signal	  has	  to	  be	  monitored	  every	  two	  minutes	  until	  the	  signal	  goes	  down.	  	  
Technically,	   this	   device	   is	   composed	   of	   a	   light-­‐tight	   imaging	   chamber,	   coupled	   to	   a	   highly-­‐
sensitive	  CCD	  camera	  system,	  an	  optical	  filter	  wheel	  and	  an	  acquisition	  computer.	  The	  Living	  Image	  
Software	  provides	  an	   interface	   for	   imaging	  and	  data	  collection.	  The	   imaging	  chamber	  consists	  of	  a	  
housing	   chamber	   in	  which	   up	   to	   five	  mice	   can	   be	   placed	   for	   imaging	   and	   a	   heated	   and	  moveable	  
platform.	  The	  mice	  are	  maintained	  under	  temporary	  anesthesia	  thanks	  an	  integrated	  isoflurane	  gas	  
manifold.	  	  
	  
Figure	  13:	  	  Bioluminescence	  imaging	  of	  mice	  orthotopically	  transplanted	  with	  luciferase-­‐transduced	  cells16	  
Organ	  extraction	  and	  sample	  handling	  	  
	  
The	  tumor	  cells	  chosen	  for	  these	  studies	  are	  quite	  aggressive	  and	  could	  establish	  metastases	  
at	   different	   locations	   rapidly	   given	   the	   genetic	   background.	   That’s	   why,	   the	   wild	   type	   mice	   were	  
sacrificed	  20	  days	  after	   the	  tail	  vein	   injection,	   instead	  of	  23	  days	   for	   the	  NALP3	  KO	  mice:	  since	  the	  
B16-­‐F10	  are	  not	  so	  fit	  in	  establishing	  metastases	  in	  such	  down-­‐regulated	  inflammatory	  background,	  
we	  waited	  until	  a	  same	  late	  stage	  signal	  on	  the	  xenogen	  was	  obtained	  to	  sacrifice	  them.	  	  
At	  this	  point,	  the	  most	  important	  is	  to	  conserve	  the	  quality	  and	  integrity	  of	  the	  RNAs,	  easily	  
degraded	  by	  RNases:	   	   the	  extraction	  of	  organs	   from	  mice	  has	   to	  be	  very	   fast.	   The	   lungs	  and	   livers	  
were	   thus	  directly	  put	   in	   liquid	  nitrogen	  and	  kept	  all	   the	   time	  at	   -­‐80°C.	  A	  cryostat	  was	  used	   to	  cut	  
14μm	  thick	  frozen	  tissue	  sections,	  directly	  used	  for	  laser	  capture	  microdissection.	  	  
Microdissections	  assisted	  with	  the	  laser	  capture:	  Laser	  Capture	  Microdissection	  LCM	  
	  
Laser	   assisted	   microdissection	   allows	   isolating	   precisely	   specific	   cell	   populations	   from	  
microscopic	  regions	  of	  tissue	  samples.	  	  
In	   this	   case,	   the	   μCut	   Laser	   Microdissector	   System	   (Nikon)	   was	   used	   in	   order	   to	   isolate	  
specific	   samples	  of	  B16-­‐F10	   tumor	   cells.	   Indeed,	   these	   cells	   established	  metastases	   in	   the	   lungs	  of	  
wild-­‐type	  and	  NALP3	  KO	  C57BL6	  mice.	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   The	   device	   is	   composed	   of	   an	   inverted	  microscope	   (Nikon	   Eclipse	   TE200)	   equipped	  with	   a	  
motorized	  scanning	  stage	  assisting	  the	  CCD	  camera	  coupled	  to	  the	  computer.	  A	  laser	  and	  an	  optical-­‐
electronical	  coupling	  unit	  also	  belong	  to	  the	  system.	  The	  associated	  software,	  μCut	  software	  (V	  1.01,	  
SL	   Microtest),	   allows	   the	   user	   to	   precisely	   focus	   on	   the	   desired	   regions	   of	   the	   samples	   and	   to	  
examine	  the	  nature	  of	  the	  given	  cells,	  since	  the	  camera	  is	  coupled	  to	  the	  objective	  and	  transfers	  the	  
images	   of	   the	   histological	   sections	   to	   the	   computer.	   Moreover,	   the	   software	   contains	   precise	  
drawing	  tools	  used	  to	  encircle	  cells	  or	  populations	  of	  interest	  with	  high	  accuracy	  and	  precision	  in	  the	  
cell-­‐scale.	  	  
Here	  is	  a	  brief	  description	  of	  the	  whole	  procedure.	  After	  mounting	  the	  frozen	  tissue	  sections	  
on	   the	   polyvinyl	   membrane	   of	   the	   special	   LCM	   slides,	   the	   tissue	   sections	   are	   fixed,	   stained	   and	  
dehydrated	  following	  a	  defined	  protocol.	  Three	  ethanol	  baths	  of	  95%,	  70%	  and	  50%	  allow	  fixing	  of	  
the	   tissue	  and	  dissolution	  of	   the	  organ	  embedding	  gel.	  Then	  toluidine	  blue	   (1%	   in	  DEPC	  water	  and	  
0,45	  μm	  filtered)	  is	  used	  to	  stain	  the	  cells.	  This	  dye	  is	  simpler	  to	  use	  than	  hematoxylin-­‐eosin	  stain	  and	  
also	   quicker.	   Moreover,	   only	   one	   dye	   is	   required	   to	   color	   different	   cellular	   component	   in	   a	  
metachromatic	  way.	  DEPC	  water	  is	  important	  in	  this	  process	  since	  it	  is	  water	  in	  which	  all	  RNases	  are	  
inactivated	   by	   the	   addition	   of	   0.1%	   of	   diethylpyrocarbonate	   (DEPC)	   to	   deionized	  water,	   incubated	  
overnight	  and	  autoclaved.	  Ten	  seconds	  are	  required	  to	  stain	  the	  tissue	  sections	  and	  then	  3	  baths	  in	  
DEPC	  water	  rinse	  the	  slide.	  Finally	  30	  seconds	  in	  70%	  EtOH	  are	  required	  to	  dehydrate	  the	  samples,	  a	  
crucial	   step	   in	   the	  procedure	  since	  residual	  moisture	  would	  enhance	  hydrostatic	   forces	  making	  the	  
sample	   more	   difficult	   to	   separate	   from	   the	   slide	   and	   surrounding	   tissue.	   	   Thereafter,	   the	   slide	   is	  
placed	  on	  the	  microdissector	  system	  using	  a	  glass	  slide	  as	  support.	  The	  user	  can	  then	  visualize	   the	  
slide	  and	  predefine	  a	  track	  along	  which	  the	  laser	  has	  to	  cut,	  without	  radiating	  the	  selected	  cells.	  After	  
the	  cut,	  a	  special	  collection	  tube	  is	  used:	  it	  contains	  a	  compact	  lid	  with	  specific	  adhesive	  properties.	  
When	   it	   is	   placed	   on	   the	   dissected	   samples,	   the	   latter	   get	   trapped	   by	   the	   cap.	   The	  whole	   cutting	  
process	   has	   to	   be	   done	   in	   20	  minutes	   to	   preserve	   the	   RNA	   integrity.	   Then,	   the	   lysis	   buffer	   of	   the	  
RNaqueous®	  Micro	  	  Kit	   is	  added	  and	  put	  30	  minutes	  at	  42°C	  and	  can	  be	  freezed	  for	  further	  sample	  
processing.	  Total	  RNAs	  were	  extracted	  from	  the	  samples	  (as	  described	  above)	  in	  order	  to	  proceed	  to	  
microarray	  analysis.	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Figure	  14	  :	  (A)	  scheme	  depicting	  the	  arrangement	  of	  the	  LCM	  slide	  on	  the	  glass	  support	  and	  the	  position	  of	  the	  
tissue	  in	  between.	  	  Example	  of	  microdissection	  of	  a	  lung	  section	  placed	  on	  the	  membrane	  of	  a	  LCM	  slide.	  (B)	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Section	  before	  the	  removal	  of	  the	  microdissected	  tumor	  region,	  (C)	  after	  the	  cut	  and	  removal	  of	  the	  area	  of	  
interest	  with	  the	  lid	  of	  the	  cap	  	  /	  	  	  Magnification	  :	  100x	  	  
Extraction	  of	  macrophages	  from	  tumor	  microenvironment	  
	  
B16-­‐F10	  cells	  were	  tail	  vein	  injected,	  500’000	  cells/mouse,	  into	  2	  WT	  and	  2	  NALP3	  KO	  female	  
mice.	  See	  section	  “Assay	  of	  metastasis”	  for	  cells	  preparation.	  After	  2	  weeks,	  mice	  were	  sacrificed	  and	  
lungs	  and	  ovaries	  of	   these	  mice	  were	  extracted	  so	   that	  macrophages	   in	  contact	  with	   tumor	  niches	  
could	   be	   isolated.	   The	   ovaries	   of	   mice	   were	   also	   taken	   since	   they	   were	   bigger	   than	   normally,	  
suggesting	  a	  possible	  strong	  infiltration	  of	  tumor	  cells.	  	  	  
Concerning	  the	  extraction	  protocol,	  it	  is	  as	  follows:	  	  
1. A	  collagenase	  solution	  made	  of	  Collagenase	  II	  (Sigma),	  Collagenase	  IV	  (Sigma)	  and	  10mM	  
Glucose	   is	   mixed	   to	   the	   extracted	   material,	   lungs	   and	   ovaries	   here,	   that	   have	   been	  
previously	  hashed	  with	  a	  razor	  blade.	  The	  incubation	  lasts	  1	  hour	  at	  37°C	  under	  agitation.	  	  
2. The	  suspension	  obtained	  is	  filtered	  through	  a	  100	  µm	  nylon	  filter	  to	  remove	  debris.	  	  
3. The	   cells	   are	   then	   pelleted	   and	   the	   supernatant	   removed.	   An	   erythrolysis	   solution	   is	  
added	   for	   exactly	   8	   minutes,	   thereafter,	   PBS	   dissolves	   this	   solution	   and	   the	   whole	   is	  
centrifuged.	  	  
4. Cells	  are	  individualized	  by	  passing	  through	  a	  FACS	  tube	  lid.	  	  
5. The	  cell	  isolation	  can	  then	  be	  processed	  following	  the	  Miltenyi	  MACS	  protocol.	  
	  
Magnetic	  Beads	  Cell	  Sorting	  	  -­‐	  MACS	  technology	  
	  
The	  principle	  of	  MACS-­‐Magnetic	  Cell	  Sorting	  is	  the	  following:	  an	  antibody	  that	  is	  coupled	  to	  
microbeads	  is	  added	  to	  the	  cell	  suspension	  and	  it	  tags	  the	  positive	  cells.	  In	  our	  case,	  the	  microbeads	  
are	  conjugated	  to	  monoclonal	  rat-­‐antimouse	  CD11b	  antibodies.	  It	  allows	  positive	  selection	  of	  mouse	  
monocytes	  and	  macrophages.	  	  
The	  positive	  cells	  are	  thus	  magnetically	  labeled	  thanks	  microbeads.	  Then,	  the	  cell	  suspension	  
is	   loaded	   onto	   a	   MACS	   Column.	   The	   latter	   is	   placed	   in	   the	   magnetic	   field	   created	   by	   the	   MACS	  
Separator.	  Thus,	  the	  magnetically	  labeled	  cells	  are	  retained	  on	  the	  column	  while	  unlabeled	  cells	  run	  
through,	   a	   fraction	   depleted	   in	   CD11b+	   cells,	   the	   negative	   fraction.	   Finally,	   to	   recover	   only	   the	  
positive	  cells,	  the	  column	  is	  removed	  from	  the	  MACS	  separator	  and	  the	  remaining	  cells	  can	  be	  eluted	  
as	  a	  positive	  cell	  fraction.	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4.	  RESULTS	  	  
	  
Preliminary	  experiments	  
Co-­‐cultures	  of	  tumors	  cells	  and	  macrophages	  
	   	  
	   As	  a	  preliminary	  experiment,	  co-­‐culture	  of	  tumor	  cells,	  in	  this	  case	  LLC	  and	  B16-­‐F10	  cells,	  and	  
macrophages	  that	  are	  either	  WT	  or	  knock-­‐out	  for	  the	  NALP3	  gene	  was	  performed.	  	  
This	  experiment	  was	  launched	  to	  detect	  and	  analyze	  changes	  in	  IL-­‐1β	  gene	  expression,	  either	  
at	  the	  mRNA	  or	  protein	  level.	  Because	  IL-­‐1β	  is	  a	  key	  mediator	  of	  inflammation,	  we	  assayed	  its	  effect	  
on	   tumor	   growth	   and	   progression.	   The	   premise	  was	   that	   it	   could	   provide	   us	  with	   clues	   about	   the	  
influence	  of	  macrophages	  on	  tumor	  cells	  and	  vice	  versa.	  Although	  the	  addition	  of	  LPS	  and	  ATP	  to	  the	  
medium	  activates	  macrophages,	  signaling	  cascades	  could	  differ	  according	  to	  the	  genetic	  background	  
of	  macrophages.	  They	  could	  also	  vary	  as	  a	  function	  of	  the	  tumor	  cell	  type.	  	  
	  
Tumor	  cells	  and	  macrophages	  were	  seeded	  either	  in	  the	  inserts	  or	  in	  the	  wells	  as	  described	  
above.	  After	  stimulation	  by	  LPS	  and	  ATP:	  	  	  
-­‐	  	  Supernatants	  and	  cell	  lysates	  were	  retrieved	  for	  further	  Western	  Blot	  experiments.	  	  
-­‐	  	  A	  duplicate	  set	  was	  made	  to	  extract	  the	  total	  RNAs	  from	  cells.	  
	  
RT	  qPCR	  results	  
	  
RT	  qPCR	  was	  performed	  on	  genes	  involved	  in	  IL-­‐1β	  processing	  including	  IL-­‐1β	  itself,	  mIL-­‐1R1	  
and	  mNALP3.	  mβ-­‐actin	  was	  used	  as	   reference	  gene.	  Co-­‐cultures	  were	  done	   in	   triplicate	  along	  with	  
RNA	   extraction	   and	   RT	   qPCR.	   Each	   time,	   the	   standard	   protocol	   was	   used,	   as	   described	   above.	  
Expression	  levels	  of	  the	  different	  mRNA	  are	  shown	  thereafter.	  	  
1. IL-­‐1β	  expression	  :	  
Unexpectedly,	  the	  two	  tumor	  cell	  types	  displayed	  opposite	  behavior:	  
-­‐	  While	   an	   activated	  microenvironment	   (WT	  macrophage)	   decreased	  mIL-­‐1β	   expression	   in	  
B16-­‐F10	   cells,	   the	   presence	   of	   KO	  macrophages	   did	   not	   change	   its	   expression	   level,	   compared	   to	  
tumor	  cells	  cultured	  alone.	  This	  was	  unexpected	  since	  KO	  macrophages	  express	  no	  active	  IL-­‐1β.	  	  
-­‐	   LLC	   put	   in	   co-­‐culture	   express	   more	   mIL-­‐1β	   than	   cultured	   alone.	   Moreover,	   since	   IL-­‐1	   β	  
induces	  its	  own	  expression,	  we	  could	  expect	  to	  see	  an	  auto-­‐amplifying	  loop.	  However,	  the	  co-­‐culture	  
with	   macrophages	   (either	   WT	   or	   KO)	   without	   any	   supplemental	   stimulation	   also	   led	   to	   an	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Graph	  1:	  mIL-­‐1β	  expression	  level	  in	  tumor	  cells	  co-­‐cultured	  with	  macrophages	  
	  
The	   observed	   difference	   in	   response	   between	   the	   two	   tumor	   types	   is	   intriguing	   given	   the	  
importance	   of	   IL-­‐1β	   in	   a	   normal	   microenvironment	   where	   it	   activates	   the	   immune	   response.	  We	  
could	  therefore	  speculate	  that	  LLC	  uses	  activated	  microenvironment	  to	  further	  promote	  activation	  of	  
the	   stroma.	   Contrary,	   IL-­‐1β	   present	   in	   the	   microenvironment	   of	   B16	   F10	   tends	   to	   diminish	   their	  
production	  of	  this	  cytokine.	  	  
This	   difference	   in	   cytokine	   production	   could	   be	   one	   explanation	   for	   the	   two	   types	   of	   cell	  
propagation	   in	   the	   KO	   background:	   LLC	   secrete	   more	   IL-­‐1β	   to	   better	   manipulate	   normal	  
microenvironment	  and	  B16-­‐F10	  appear	  to	  undergo	  inhibition	  of	  IL-­‐1β	  secretion,	  a	  failure	  that	  impairs	  
their	  progression.	  	  
However,	  interpretation	  of	  these	  data	  has	  to	  be	  done	  with	  care	  since	  the	  mRNA	  level	  of	  IL-­‐1β	  is	  
not	  representative	  of	  the	  amount	  of	  processed	  and	  active	  IL-­‐1β	  that	  is	  secreted	  by	  the	  cells.	  	  
	  
Macrophages	   co-­‐cultured	   with	   both	   tumor	   cell	   types	   increased	   their	   basal	   level	   of	   IL-­‐1β	  
expression.	   Especially	   for	   KO	  macrophages,	   the	   expression	   level	   remained	   high	   since	   the	  mRNA	   is	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Graph	  2:	  mIL-­‐1β	  expression	  level	  in	  macrophages	  either	  WT	  or	  KO,	  in	  co-­‐culture	  with	  tumor	  cells	  
	  
2. Il-­‐1R1	  expression:	  	  
	  
mIL-­‐1R1	  expression	   level	   in	  both	   tumor	   types	   in	  standard	  culture	   is	  different:	  B16-­‐F10	  mIL-­‐1R1	  
was	  detected	  on	  the	  qPCR	  at	  the	  37th	  cycle	  whereas	  for	  LLC,	  mIL-­‐1R1	  is	  already	  	  distinguished	  at	  the	  
22nd	  cycle,	  representing	  a	  15’000	  fold	  difference.	  	  	  
Secondly,	   the	   co-­‐cultures	   and	   presence	   or	   not	   of	   ATP/LPS	   did	   not	   significantly	   influence	   the	  
receptor	  expression	  level	  in	  LLC.	  For	  B16-­‐F10,	  presence	  of	  activated	  macrophages	  induced	  more	  mIL-­‐
1R1,	   an	   observation	   that	   was	   not	   made	   in	   the	   presence	   KO	   macrophages	   where	   the	   level	   was	  
comparable	  to	  the	  control	  case.	  
Activation	  of	  macrophages	  with	  ATP/LPS	  induced	  up-­‐regulation	  of	  the	  IL-­‐1R1	  gene	  comparably	  to	  
co-­‐culture	   conditions.	   Up-­‐regulation	   was	   also	   lower	   in	   KO	   macrophages.	   This	   point	   seems	  
contradictory	   since	   impaired	   secretion	   of	   IL-­‐1β	   may	   be	   expected	   to	   induce	   up-­‐regulation	   of	   the	  
receptor	  to	  better	  sense	  the	  microenvironment	  because	  of	  the	  depletion	  of	  IL-­‐1β.	  
	  
In	   this	   case,	   a	   point	   worth	   to	   investigate	   is	   the	   functional	   consequences	   of	   the	   difference	   in	  
receptor	   expression	   between	   the	   two	   tumor	   cell	   lines.	   The	   next	   step	   is	   first	   of	   all	   to	   detect	   and	  
quantify	  this	  receptor	  at	  protein	  level	  by	  the	  use	  of	  a	  Western	  Blot.	  Then,	  down-­‐and	  up-­‐regulation	  of	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Graph	  3:	  mIL-­‐1R1	  expression	  level	  in	  macrophages	  in	  co-­‐culture	  with	  tumor	  cells	  	  
3. mNALP3	  expression:	  	  
Presence	   of	  macrophages	   induces	   the	   production	   of	  mNALP3	   in	   both	   cell	   lines	  where	   the	   up-­‐
regulation	   of	   it	   is	   observed.	   Differences	   arise	   depending	   on	   the	   genetic	   background	   of	   the	  
macrophages,	  either	  WT	  or	  KO,	  that	  are	  in	  co-­‐culture.	  This	  is	  explained	  by	  the	  fact	  that	  immune	  cells	  
produce	  a	  plethora	  of	  inflammatory	  cytokines	  which	  may	  induce	  various	  reactions	  from	  tumor	  cells.	  
Up-­‐regulation	   of	   NALP3	   would	   allow	   more	   IL-­‐1β	   processing,	   a	   notion	   that	   is	   consistent	   with	   the	  
observation	  that	  more	  IL-­‐1β	  is	  produced	  by	  LLC.	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   NALP3	   in	   macrophages	   subjected	   to	   ATP/LPS	   was	   up-­‐regulated	   up	   to	   5	   fold.	   Co-­‐cultures	  
reveal	   that	   NALP3	   expression	   is	   affected	   by	   the	   presence	   of	   tumor	   cells	   since	   its	   expression	   is	  
decreased	  in	  both	  macrophages	  as	  well	  as	  in	  tumor	  cells.	  	  
	  
	   In	   conclusion	   to	   this	   experiment,	  we	   could	   analyze	   the	   changes	   induced	   by	   co-­‐cultures	   on	  
three	  IL-­‐1β	  related	  molecules	  and	  point	  out	  the	  differences	  between	  the	  two	  selected	  cell	   lines.	  To	  
better	   figure	   out	   the	   complex	   mechanisms	   regulating	   these	   different	   points,	   the	   next	   step	   is	   to	  
broaden	  the	  spectrum	  of	  genes	  analyzed	  by	  performing	  microarrays	  analyses.	  	  
	  
RT	  qPCR	  on	  microRNAs	  	  
	  
Since	  microRNAs	  are	  also	  described	  to	  be	   involved	   in	  the	  regulation	  of	   immune	  system,	  we	  
chose	   to	   figure	  out	   the	  expression	  pattern	  of	   some	  known	  microRNAs	   in	   the	  macrophages	  used	   in	  
our	  experiments,	  either	  WT	  or	  KO.	  	  
The	   first	   experiment	   allowed	   analyzing	   the	   differences	   in	   expression	   of	   mir-­‐140-­‐5p	   in	  
macrophages,	  with	  addition	  or	  not	  of	  LPS	  and/or	  ATP.	  Rnu-­‐5g	  was	  taken	  as	  reference	   in	  this	  qPCR.	  
Mir-­‐140	  was	  shown	  in	  previous	  studies	  to	  be	  decreased	  upon	  addition	  of	  IL-­‐1β.	  Here,	  LPS	  and/or	  ATP	  
treatment	  of	  macrophages	  induces	  secretion	  of	  IL-­‐1β.	  It	  will	  then	  decrease	  mir-­‐140	  expression.	  	  
Practically,	  we	  observed	  that,	   indeed,	  the	  induced	  IL-­‐1β	  decreased	  in	  the	  expression	  of	  mir-­‐
140-­‐5p.	  LPS	  also	  had	  a	  stronger	  effect	  than	  ATP	  in	  this	  inhibition.	  Mir-­‐140-­‐5p	  expression	  level	  in	  KO	  
macrophages	  was	  however	  higher	  than	   in	  WT	  macrophages.	  This	  can	  be	  explained	  by	  the	  fact	   that	  
these	   KO	   cells	   do	   not	   secrete	   IL-­‐1β	   as	  much	   as	  WT	  macrophages	   do,	   the	   inhibition	   of	   mir-­‐140	   is	  
therefore	  not	  as	  important.	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Western	  Blots	  	  
	  
Supernatant	  and	  cell	   lysates	  were	  also	   isolated	  from	  co-­‐cultures.	  The	  presence	  of	   IL-­‐1β	  was	  
assessed,	  either	  in	  the	  cell	  lysate	  or	  in	  the	  supernatants.	  	  
Normalization	   in	   this	   case	   was	   made	   using	   the	   Ponceau	   staining:	   Photoshop	   was	   used	   to	  
determine	   whether	   the	   pixel	   intensity	   for	   the	   band	   at	   26kD	   is	   the	   same	   in	   each	   well.	   IL-­‐1β	   was	  
detected	  in	  supernatant	  of	  WT	  macrophages	  cultured	  alone	  as	  well	  as	  WT	  macrophages	  in	  co-­‐culture	  
with	  LLC.	   	  Note	  also	  that	  without	  LPS/ATP	  treatment,	  this	  active	  protein	  was	  absent.	  Moreover,	  KO	  
macrophages	  did	  not	  secrete	  the	  active	  form.	  IL-­‐1β	  proform	  was	  detected	  in	  the	  supernatant	  of	  co-­‐
cultured	  WT	  and	  KO	  macrophages,	  revealing	  that	  this	  molecule	  gets	  exo-­‐cytosed	  in	  the	  unprocessed	  
form.	  	  
	  








Figure	  4.1:	  A)	  Ponceau	  staining	  realized	  on	  membrane	  representing	  the	  supernatant	  samples,	  used	  for	  normalization	  of	  the	  
blot.	  B)	  WB	  detecting	  IL-­‐1β,	  made	  on	  supernatant	  of	  Macrophages	  co-­‐cultured	  with	  LLC	  	  (femto	  5	  min)	  
	  
Now	  regarding	  cell	  lysates,	  western	  blots	  were	  realized	  to	  detect	  IL-­‐1β	  and	  IL-­‐1R1.	  The	  
following	  table	  shows	  the	  obtained	  results	  for	  the	  detection	  of	  IL-­‐1β:	  	  
A	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Figure	  4.2:	  A)	  Cell	  lysate	  of	  macrophages	  alone	  or	  in	  co-­‐culture	  with	  LLC	  	  B)Cell	  lysate	  of	  LLC	  alone	  or	  in	  co-­‐
culture	  with	  macrophages	  
	   From	   Figure	   4.2,	  macrophages	   alone,	   either	  WT	   or	   KO,	   showed	   high	   amount	   of	   pro-­‐IL-­‐1β,	  
especially	  upon	  addition	  of	  LPS/ATP.	  In	  co-­‐cultures	  too,	  the	  pro-­‐form	  was	  detected,	  especially	  in	  KO	  
macrophages	   in	   presence	   of	   LPS/ATP.	   An	   accumulation	   of	   this	   protein	   happened	   here,	   probably	  
because	  it	  cannot	  be	  processed.	  	  
On	  the	  side	  of	  LLC,	  the	  co-­‐culture	  strengthened	  the	  expression	  of	  the	  pro-­‐form	  of	   IL-­‐1β.	  To	  
test	   the	   influence	   of	   LPS/ATP	   on	   them,	   we	   also	   cultured	   these	   cells	   alone	   with	   or	   without	   these	  
chemicals.	  We	  could	  see	  a	  slight	  activation	  of	  the	  gene	  since	  more	  pro-­‐form	  was	  detected	  upon	  their	  
addition.	  	  
	  
	   The	  western	  performed	   to	  detect	   IL-­‐1R1	   in	   cell	   lysates	  was	   too	  noisy	   to	  perceive	   the	   right	  
80kD	  band.	  	  The	  IL-­‐1R1	  anti-­‐body	  used	  was	  subjected	  to	  different	  dilution	  tests	  to	  optimize	  its	  use.	  	  
	  
IL-­‐1R1	  :	  silencing	  and	  overexpression	  
	  
As	  explained	  in	  the	  previous	  paragraph,	  the	  observed	  difference	  in	  IL-­‐1R1	  in	  the	  two	  cell	  lines	  
especially	  aroused	  our	  curiosity:	  could	  this	  receptor	  be	  implicated	  in	  the	  metastatic	  capacity	  of	  either	  
of	  these	  two	  different	  cell	  types?	  	  	  
To	   answer	   this	   question,	   the	   first	   thing	   we	   did	   was	   to	   either	   silence	   or	   overexpress	   this	  
receptor	  in	  tumor	  cells.	  The	  silencing	  was	  designed	  using	  a	  small	  hairpin	  (sh)	  and	  induced	  in	  the	  two	  
selected	  tumor	  cell	  lines.	  Then,	  the	  overexpression	  procedure	  was	  realized.	  The	  correct	  silencing	  and	  
overexpression	  of	  the	  gene	  were	  then	  tested	  using	  standard	  RT	  qPCR	  protocols.	  	  
Here	   followings	   are	   the	   results	   of	   the	   qPCR	   made	   on	   both	   B16-­‐F10	   and	   LLC	   tumor	   cells	  
transformed	  with:	  
-­‐ sh762	  representing	  the	  most	  efficient	  silencer	  of	  IL-­‐1R1	  
-­‐ sh916	  is	  a	  less	  efficient	  silencer	  for	  the	  same	  mRNA	  
-­‐ shCTL	  represents	  the	  negative	  control.	  	  
-­‐ OVER	  sample	  stands	  for	  the	  cells	  that	  were	  infected	  with	  the	  virus	  containing	  the	  
overexpression	  construct.	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RT-­‐qPCR	  
	  
1. mIL-­‐1R1	  expression	  level	  
	  
We	  can	  see	  a	  difference	  in	  efficacy	  of	  the	  down-­‐regulation	  in	  the	  two	  types	  of	  cells:	  B16	  F10	  
clearly	  showed	  lower	  expression	  of	  mIL-­‐1R1	  than	  LLC,	  indicating	  a	  more	  efficient	  down-­‐regulation	  in	  
them.	  This	  could	  arise	  from	  different	  in	  virus	  penetration	  of	  the	  cells.	  Nevertheless,	  since	  LLC	  express	  
mIL-­‐1R1	  15’000	   fold	  more	   than	  B16	  F10,	   the	  sh	  could	  work	  and	  decrease	   the	  expression	   level	   to	  a	  
value	  that	  is	  still	  high	  enough	  and	  thus,	  the	  down-­‐regulation	  is	  unnoticeable.	  	  	  
	   This	  difference	   in	  efficacy	  was	  also	  observed	   for	   the	  overexpression.	   It	  worked	  very	  well	   in	  




Graph	  6:	  mIL-­‐1R1	  expression	  level	  in	  B16-­‐F10	  and	  LLC	  cells,	  upon	  downregulation	  of	  the	  receptor	  
	  
	   	  
Tumor	  cell	  type	   sh	  CTL	   OVER-­‐expression	  
B16-­‐F10	   1.00	   2144.60	  
LLC	   1.00	   4.27	  
	  
Table	  2:	  mIL-­‐1R1	  expression	  level	  in	  tumor	  cells,	  upon	  overexpression	  of	  the	  receptor	  
	  
	  
2. mIL-­‐1β	  expression	  level	  
	  
With	  the	  most	  efficient	  sh,	  the	  sh762,	  mIL-­‐1β	  expression	  level	  was	  higher	  than	  in	  the	  control,	  




































mIl-­‐1R1	  expression	  in	  LLC	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Graph	  7:	  mIL-­‐1β	  expression	  level	  in	  B16-­‐F10	  and	  LLC	  cells,	  	  with	  up-­‐	  or	  downregulation	  of	  the	  receptor	  
	  
3. mIL-­‐18	  expression	  level	  	  
This	  cytokine	  is	  a	  target	  gene	  of	  IL-­‐1	  signaling	  and	  its	  own	  signaling	  cascade	  shares	  different	  
intermediate	  mediators.	  Here	  what	  was	  observed	  was	  that	  mIL-­‐18	  was	  upregulated	  in	  both	  down-­‐	  or	  
up-­‐regulation	  of	  the	  receptor	  IL-­‐1R1.	  	  	  
	  
Graph	  8:	  mIL-­‐18	  expression	  level	  in	  B16-­‐F10	  and	  LLC	  cells,	  upon	  downregulation	  of	  the	  receptor	  
	   Shared	  intermediates	  in	  the	  signaling	  pathway	  such	  as	  MyD88	  or	  IRAK	  were	  not	  analyzed	  but	  
we	   reckon	   that	   every	   step	   could	   stand	   for	   the	   rate	   limiting	   point	   of	   the	   cascade	   and	  would	   thus	  
require	  deeper	  investigations	  upon	  these	  specific	  genetic	  modifications.	  	  
Western	  blot	  
	   After	   having	   analyzed	   the	   mRNA	   levels,	   the	   next	   step	   was	   to	   check	   the	   effect	   of	   the	  
modifications	  on	  protein	  level.	  	  The	   results	  of	   the	  western	  blot	  performed	  on	  B16	  F10	  cell	   lysate	   to	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Figure	  4.3:	  IL-­‐1R1	  western	  blot	  detection	  on	  B16	  F10	  cell	  lysate	  
	   As	   we	   can	   see,	   this	   western	   blot	   showed	   a	   lot	   of	   background	   noise	   that	   could	   arise	   for	  
different	  reasons:	  	  
× The	   blocking	   with	  milk	   was	   not	   sufficient	   in	   terms	   of	   time:	   a	   longer	   blocking	   step	  
could	  improve	  the	  efficiency	  of	  the	  primary	  antibody	  
× The	  incubation	  with	  primary	  anti-­‐body	  at	  4°C	  instead	  of	  room	  temperature	  would	  be	  
more	  efficient,	  since	  high	  temperature	  increases	  the	  risk	  of	  off-­‐target	  recognitions.	  
× It	   can	   also	   be	   the	   result	   of	   a	   secondary	   antibody	   that	   recognizes	   different	   non-­‐
specific	  targets.	  	  
Proliferation	  Assay	  
When	  a	  genetic	  modification	  is	  introduced	  in	  a	  cell	  line,	  the	  potential	  changes	  induced	  at	  the	  
proliferative	  levels	  have	  also	  to	  be	  checked.	  	  
The	  results	  of	  the	  proliferation	  assay	  are	  presented	  in	  the	  graph	  9	   in	  which	  the	  principle	   is:	  
the	  higher	  the	  measured	  absorbance,	  the	  higher	  the	  proliferation	  rate.	  No	  significant	  differences	  in	  
proliferation	   were	   observed.	   	   In	   B16-­‐F10,	   the	   downregulation	   of	   the	   receptor	   provoked	   a	   slight	  
decrease	   in	   proliferation.	   Since	   the	   absorbance	   is	   proportional	   to	   the	   formazan	   quantity	   released	  
from	   cell,	   it	  mainly	   depends	  on	   the	  physiological	   state	  of	   the	   cells,	   a	   factor	   that	   can	  differ	   in	   cells	  





























Prolifera`on	  Assay:	  	  LLC/B16	  :	  up	  /	  down	  reg	  Il1R1	  
540nm	  B16	  
540nm	  LLC	  
	   	   46	  
Graph	  9:	  Proliferation	  assay	  made	  tumor	  cells,	  with	  over	  or	  down-­‐regulation	  of	  the	  IL-­‐1R1	  receptor	  
Migration	  Assay	  
	   A	  migration	  assay	  was	  also	  performed	  to	  check	   the	  ability	  of	  modified	  cells	   to	  migrate	  and	  
thus	  to	  heal	  wounds.	  Here	  following	  is	  the	  analysis	  process	  of	  the	  different	  pictures	  taken	  during	  the	  
experiment	   to	   follow	   the	   migration	   of	   both	   cell	   types.	   This	   was	   made	   using	   different	   ImageJ	  
manipulations	  as	  described	  in	  Figure	  4.4.A).	  	  
Since	  B16	   F10	  have	   a	   completely	   different	  morphology	   compared	   to	   the	   round	   LLC,	   it	  was	  
choose	  not	   to	  count	   them	  but	   to	  define	  the	  percentage	  of	   the	  scar	  zone	  that	  was	  occupied	  by	  the	  
cells	  at	  every	  time	  point(see	  Figure	  4.4.4).	  
A	  
	  
1. 	  	  B16	  F10	  sh762	  at	  timepoint	  0h	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  B16	  F10	  at	  timepoint	  48h	  
	  
3. Determination	   of	   the	   surface	   occupancy	   by	  














Figure	  4.4:	  A)	  Image	  J	  processing	  	  method	  for	  the	  	  LLC	  pictures	  B)	  Images	  of	  the	  scar	  evolution	  with	  time	  in	  the	  
case	  of	  B16	  F10	  sh762	  cells	  :	  1-­‐	  at	  oh	  ,	  2-­‐	  at	  t=24h	  ,	  3-­‐	  at	  t=48h	  ,	  4-­‐	  image	  representing	  the	  way	  of	  analyzing	  the	  
surface	  of	  the	  scar	  the	  migrating	  cells	  do	  cover	  
Two	  measures	  were	  computed:	  either	  the	  scar	  size	  with	  time	  or	  the	  percentage	  of	  the	  scar	  
area	  that	  was	  re-­‐occupied	  with	  cells.	  	  
In	   the	   case	   of	   LLC,	   the	   number	   of	   cells	   present	   in	   the	   scar	   zone	   was	   counted	   and	   then,	  
approximating	   the	  size	  of	  a	   round	  LLC	  cell,	   the	  surface	  area	  could	  be	  determined.	  For	   the	  B16	  F10	  
cells,	  the	  percentage	  of	  scar	  re-­‐occupation	  could	  be	  computed	  by	  determining	  the	  zone	  of	  the	  scar	  
occupied	  by	  cells	  (Figure	  4.4.4).	  The	  obtained	  graphs	  are	  shown	  below.	  	  	  
Migration	  was	  not	  impaired	  by	  any	  of	  the	  three	  genetic	  modifications	  in	  B16	  F10	  cells,	  as	   it	  
can	  be	  seen	  in	  graph	  10.	  However,	  the	  migratory	  rate	  was	  not	  equal	  for	  all	  the	  conditions.	  
Graph	  11.A)	  shows	  the	  percentage	  of	  scar	  area	  that	  was	  covered	  by	   tumor	  cells	  with	   time:	  
B16	   F10	   sh762	   cells	   did	  migrate	  more	  quickly	   at	   the	  beginning:	   after	   24	  hours,	   double	  quantity	  of	  
cells	  was	   already	   investigating	   the	   scar.	  However,	   at	   48	  hours,	   every	   cell	   type	   showed	   similar	   scar	  
occupancy.	   The	   pictures	   were	   taken	   in	   this	   case	   every	   24	   hours.	   To	   better	   follow	   the	   migration	  
process,	  it	  could	  have	  been	  more	  instructive	  to	  have	  taken	  pictures	  every	  6	  hours.	  	  
Scar	   size	   was	   decreasing	   linearly	   with	   time	   especially	   for	   the	   OVER	   case.	   It	   reflects	   the	  
stronger	  ability	  of	  B16	  F10	  OVER	  to	  investigate	  the	  scar	  more	  widely	  in	  the	  end.	  This	  last	  point	  could	  
also	  be	  explained	  by	  the	  increased	  proliferation	  of	  these	  cells.	  	  



































Scar	  re-­‐covering	  by	  B16	  F10	  




	   	   48	  
	  	  	  	  	  B	  
	  
	  
Graph	  10:	  A)	  Migratory	  scale	  of	  B16	  F10	  cells	  from	  scar	  timepoint	  till	  total	  confluence	  of	  cells.	  B)	  Size	  of	  the	  
scar	  for	  the	  different	  conditions	  during	  the	  time	  of	  the	  assay.	  
	  
For	   the	  LLC,	   since	   these	  cells	  are	   semi-­‐adherent,	  we	  would	  have	  expected	   that	   they	  would	  
not	  be	  able	  to	  migrate	  with	  a	  directional	  movement.	  In	  fact,	  these	  cells	  were	  also	  migrating	  as	  it	  can	  
be	  seen	  in	  figure	  11,	  with	  LLC	  sh762	  being	  the	  quicker	  ones	  since	  after	  48	  hours,	  a	  state	  of	  confluence	  
was	  achieved.	   In	  this	  case,	  the	  downregulation	  of	  the	  receptor	  did	  not	  seem	  to	  have	   increased	  the	  
migratory	  rate:	  the	  LLC	  OVER	  only	  recovered	  half	  scar	  zone	  after	  48	  hours.	  Regarding	  the	  scar	  size,	  
we	  can	  see	  that	  it	  decreased	  more	  rapidly	  in	  the	  case	  of	  LLC	  sh762.	  	  
A	  
	   	  
B	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Graph	  11:	  A)	  Migratory	  scale	  of	  LLC	  cells	  from	  scar	  timepoint	  till	  total	  confluence	  of	  cells.	  B)	  Size	  of	  the	  scar	  for	  the	  
different	  conditions	  during	  the	  time	  of	  the	  assay.	  
	  
To	   conclude	   this	   experiment,	   we	   can	   say	   that	   the	   induced	   genetic	   modifications	   did	   not	  
influence	   the	  migration	  capacity.	  However,	   these	  assays	  were	  performed	  under	  normal	  conditions,	  
with	  standard	  medium.	  To	  better	  assess	  the	  importance	  of	  the	  receptor	  up-­‐	  or	  down-­‐regulation,	  the	  
use	  an	  IL-­‐1β	  neutralizing	  antibody	  would	  block	  the	  signaling	  through	  the	  receptor	  and	  therefore,	  we	  
could	  investigate	  the	  effects	  of	  this	  inhibition	  and	  determine	  if	  IL-­‐1R1	  is	  a	  rate	  limiting	  component.	  	  
	  
Soft	  Agar	  Assay	  for	  colony	  formation	  
This	   assay	   tests	   the	   anchorage	   independent	   growth	   of	   cells.	   Moreover,	   the	   apparition	   of	  
colonies	  in	  soft	  agar	  often	  indicates	  in	  vivo	  carcinogenesis	  capacity.	  	  
	  
Concerning	   the	   B16-­‐F10	   cell,	   we	   tested	   all	   4	   constructions,	   i.e.	   sh762,	   sh916,	   shCTL	   and	  
OVER.	  Colonies	  began	  to	  appear	  at	  day	  7-­‐8	  and	  were	  significant	  at	  day	  11-­‐13.	  The	  morphology	  of	  the	  
colonies	  was	  similar,	  with	  a	  round-­‐shaped	  form	  in	  all	  cases	  but	  at	  D13,	  some	  sh762	  colonies	  already	  
began	   to	   spread	   in	  a	   star	   fashion.	  Considering	   the	  size	  of	   the	  colonies,	   it	   could	  be	  measured	  using	  
pictures	  with	  a	  same	  magnification.	  At	  D11,	  the	  sh762	  presented	  the	  bigger	  colonies:	  1,8	  fold	  bigger	  
than	  shCTL.	  In	  this	  particular	  case,	  we	  could	  observe	  more	  but	  smaller	  colonies.	  	  
However,	   except	   these	   differences	   in	   morphology	   and	   size,	   we	   could	   not	   distinguish	  
significant	   differences	   in	   the	   establishment	   of	   these	   colonies,	   indicating	   that	   the	   induced	  
modifications	  are	  not	  impairing	  the	  anchorage	  independency	  for	  B16	  F10	  cells.	  	  	  
	  
Concerning	  the	  LLC,	  we	  could	  count	  the	  number	  of	  colonies	  (under	  a	  given	  field	  of	  view,	  at	  a	  
magnification	  of	  40X)	  and	  we	  got	  the	  following	  numbers:	  
	   LLC	  sh762	   LLC	  shCTL	   LLC	  OVER	  
Number	  of	  colonies	   5	  	  (±	  2)	   6(±	  2)	   11(±2)	  
Table	  3:	  Number	  of	  colonies	  count	  for	  LLC	  cells	  in	  the	  soft	  agar	  assay	  
	  
A	   higher	   number	   of	   colonies	   was	   counted	   in	   the	   case	   of	   overexpression	   compared	   to	  
downregulation.	  Regarding	  their	  morphology,	  all	  colonies	  were	  similar	  in	  shape	  with	  a	  round	  form.	  	  
	  
	  
The	   main	   conclusion	   for	   these	   in	   vitro	   assays	   is	   that	   the	   global	   phenotype	   regarding	  
proliferation,	  migration	   and	   anchorage	   independent	   growth	   is	   conserved	   and	   not	   affected	   by	   the	  
induced	   genetic	   modifications.	   As	   preliminary	   tests,	   these	   were	   performed	   under	   standard	  
conditions,	  with	  normal	  medium	  and	  without	  other	  stimulation	  or	  perturbation.	  Then,	  different	  more	  
sophisticated	  tests	  would	  allow	  better	  understanding	  IL-­‐1R1	  importance	  in	  these	  tumor	  cells:	  	  
-­‐ change	  the	  medium	  composition	  by	  complete	  depletion	  of	  IL-­‐1β	  by	  the	  use	  of	  a	  
neutralizing	  anti-­‐body	  
-­‐ culture	  the	  cells	  with	  different	  concentrations	  of	  IL-­‐1β	  
-­‐ culture	  the	  cells	  with	  macrophage	  (WT	  or	  KO)	  culture	  medium	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-­‐ check	   downstream	  mediators	   expression	   levels	   (mRNA	   and	   protein),	   especially	  
NF-­‐κB.	  
	  	  	  
In	  vivo	  experiments	  	  
	  
After	   in	   vitro	   tests,	   the	   investigations	  at	   the	   in	   vivo	   level	  were	  done.	   Such	   in	   vivo	   tests	   are	  
more	  relevant	  and	  accurate	  to	  figure	  out	  real	   impact	  of	  genetic	  modifications,	  since	  every	  player	   is	  
represented,	  with	   complete	  microenvironment.	   To	  do	   so,	  we	  decided	   to	  perform	   two	  assays,	  with	  
each	  time,	  sh762,	  shCTL	  and	  overexpression,	  in	  B16-­‐F10	  and	  LLC:	  
-­‐ Sub-­‐cutaneous	   injections	   (500’000	  cells	   in	  each	  condition)	  were	  made	  to	  assess	  
the	  primary	  tumor	  growth	  capacity	  of	  the	  modified	  cells.	  	  
-­‐ Tail-­‐vein	   injections	   (500’000	   cells	   in	   each	   condition)	   allowed	   assessing	   the	  
metastatic	   spread,	  with	   cells	   introduced	   directly	   into	   the	   circulation,	   bypassing	  
the	  need	  of	  primary	  tumor.	  	  	  
14	   days	   after	   injections,	   the	   mice	   were	   sacrificed	   and	   the	   subcutaneous	   tumors	   were	  
retrieved,	  as	  wells	  as	  the	  lungs	  and	  livers	  for	  the	  tail-­‐vein	  injected	  mice.	  	  	  
	  
Concerning	   the	   sub-­‐cutaneous	   tumors,	   the	   primary	   observations	   were	   that	   the	  
downregulation	  of	  the	  receptor	  did	  not	  impair	  in	  vivo	  growth	  since	  the	  size	  of	  the	  tumors	  was	  smaller	  
than	   the	   control	   case	   but	   still	   present	   and	   this,	   for	   both	   tumor	   cell	   types.	   Subcutaneous	   tumor	  
volume	  could	  be	  calculated	  using	  the	  ellipsoid	  volume	  formula,	  postulated	  by	  Reynolds	  and	  Tomayko	  
to	  be	  more	  accurate	   than	   the	  spherical	   volume	   to	  determine	   real	   volume	  of	   subcutaneous	   tumors	  
[42].	  The	  ellipsoid	  formula	  is	  as	  following:	  	  	  	   ! = !! ∗ ! ∗! ∗ !	   We	   used	   it	   to	   determine	   the	  
volume	  of	  subcutaneous	  tumors.	  
	  
	   SC	  tumor	  volume	  (mm3)	   	   SC	  tumor	  volume	  (mm3)	  
B16	  F10	  sh762	   52	  mm3	  	  	  	  	  	  	  (±5	  mm3)	   LLC	  sh762	   340	  mm3	  	  	  	  (±5	  mm3)	  
B16	  F10	  shCTL	   290	  mm3	  	  	  	  (±5	  mm3)	   LLC	  shCTL	   430	  mm3	  	  	  	  	  (±5	  mm3)	  
B16	  F10	  OVER	   	  41	  mm3	  	  	  	  	  	  	  (±5	  mm3)	   LLC	  OVER	   0	  mm3	  	  	  	  	  (±5	  mm3)	  
	  
	   We	  could	  observe	  a	  difference	  in	  tumor	  size	  for	  the	  sh762	  versus	  the	  shCTL,	  confirming	  that	  
downregulation	  could	  play	  a	  role	  in	  decreasing	  growth	  capacity	  of	  the	  given	  cells.	  The	  overexpression	  
showed	  intriguing	  results:	  there	  was	  only	  a	  very	  small	  tumor	  in	  the	  case	  of	  B16-­‐F10	  cells	  and	  even	  no	  
tumor	   at	   all	   present	   for	   the	   LLC.	   This	   was	   a	   bit	   surprising,	   since	   we	   expected	   to	   improve	   tumor	  
growth	  with	  increased	  receptor	  representation	  at	  the	  cell	  surface.	  	  
	  
The	   extracted	   organs	   were	   sent	   for	   paraffin	   inclusion	   and	   hematoxylin-­‐eosin	   coloration.	  
These	  subcutaneous	  tumors	  were	  mainly	  composed	  of	  cancer	  cells	  with	  a	  high	  percentage	  of	  necrotic	  
tissues.	  The	  immune	  cells	  infiltrate	  was	  present	  but	  it	  was	  difficult	  to	  qualitatively	  quantify	  it.	  	  
	  
In	   the	   case	   of	   tail-­‐vein	   injected	  mice,	   the	   extracted	   tissues,	   lungs,	   livers	   and	   ovaries,	  were	  
fixed	   in	   paraformaldehyde	   before	   to	   be	   included	   in	   paraffin	   for	   hematoxylin-­‐eosin	   coloration.	  We	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could	  then	  count	  the	  number	  of	  metastases	  in	  every	  sample.	  Lungs	  did	  not	  present	  many	  metastases	  
compared	  to	  livers,	  this	  is	  why	  we	  chose	  to	  evaluate	  more	  deeply	  liver	  colonization.	  	  
	  
	   B16	  F10	  sh762	   B16	  F10	  	  shCTL	   B16	  F10	  OVER	  
Number	  of	  Metastases	   2	  (±1)	   4(±	  1)	   3(±2)	  
	   LLC	  sh762	   LLC	  shCTL	   LLC	  OVER	  
Number	  of	  Metastases	   4	  	  (±	  2)	   5(±	  2)	   9(±2)	  
Table	  4:	  Number	  of	  metastases	  count	  for	  B16	  F10	  and	  LLC	  TVI	  in	  livers	  extracted	  
	  
In	   the	  case	  of	   LLC,	   the	  metastases	  were	  globally	   small	   and	  widely	  dispersed	  all	   around	   the	  
liver.	  LLC	  overexpression	  presented	  more	  metastases,	  even	  if	  these	  were	  very	  small.	  LLC	  sh762	  also	  
showed	  small	  metastases,	  but	  less	  than	  with	  shCTL.	  Moreover,	  infiltrates	  were	  present,	  mainly	  next	  
to	  blood	  vessels.	  
	   For	  B16,	  we	  could	  observe	  bigger	  metastases	  but	   in	   lower	  number.	   	  sh762	  B16	  F10	  	  
presented	  metastases	  but	  these	  were	  smaller	  in	  size	  compared	  to	  shCTL.	  Necrotic	  tissue	  was	  present	  
in	  metastases	  of	  all	  three	  conditions,	  indicating	  a	  state	  of	  the	  metastases	  that	  is	  more	  advanced	  than	  
in	  the	  case	  of	  LLC.	  Infiltrates	  were	  also	  detected	  mainly	  beside	  blood	  vessel.	  	  
	  
IN	  VIVO	  studies	  	  
	  
Metastases	  gene	  expression	  profiling	   	  
	  
After	   having	   performed	   co-­‐cultures	   mimicking	   the	   inflammatory	   micro-­‐environment,	   we	  
decided	  to	  figure	  out	  the	  gene	  expression	  profile	  of	  B16-­‐F10	  metastases	  in	  both	  NALP3	  WT	  and	  KO	  
background	   in	  an	   in	  vivo	  experiment.	  To	  do	  so,	  we	  tail-­‐vein	   injected	  500’000	  B16-­‐F10	  cells	   in	  5	  WT	  
and	   5	   KO	   C57Bl/6	   mice.	   These	   tumor	   cells	   were	   normal	   concerning	   IL-­‐1R1	   expression	   but	   they	  
expressed	   luciferase	  to	   follow	  the	  establishment	  of	  metastases	  with	  Xenogen.	   	  Sacrifice	  of	  WT	  and	  
KO	  mice	  was	  not	  done	  at	  the	  same	  time	  since	  melanoma	  cells	  establish	  metastases	  more	  easily	  into	  
the	  WT	  background.	  WT	  mice	  were	  thus	  sacrificed	  at	  day	  19	  and	  KO	  at	  day	  22.	  The	  extraction	  of	  the	  
organs,	   lungs	  and	   livers,	  was	  realized	  following	  a	  specific	  protocol	   to	  avoid	  RNA	  degradation,	  being	  
directly	   snap-­‐freezed.	   Thereafter,	   LCM	   protocol	   was	   lauched	   with	   preparation	   of	   slices	   for	   every	  
sample	  followed	  by	  staining,	  dehydration,	  Laser	  Capture	  Microdissection	  and	  total	  RNA	  extraction.	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Graph	  12:	  Bioluminescent	  signal	  obtained	  of	  B16-­‐F10	  metastases	  in	  C57Bl/6	  mice	  
	  
Macrophages	  in	  contact	  with	  metastases	  gene	  expression	  profiling	  
	  
	   Since	   it	   is	   more	   relevant	   to	   isolate	   specifically	   macrophages	   that	   are	   in	   contact	   with	  
metastases	  than	  cutting	  stromal	  area	  containing	  a	  mix	  of	   immune	  cells	  by	   laser	  capture,	  we	  set	  up	  
another	   experiment:	   tail-­‐vein	   injection	   of	   B16-­‐F10	   cells	   (500’000	   cells)	   in	   both	  WT	   and	   KO	   female	  
mice,	  sacrifice	  after	  21	  days,	  extraction	  of	  organs	  followed	  by	  specific	  isolation	  of	  macrophages.	  	  
	  
	   In	   this	   experiment,	   organs	   retrieved	   were	   the	   lungs	   and	   the	   ovaries:	   B16-­‐F10	   metastatic	  
spread	  shows	  organ-­‐specificity	  in	  a	  nonrandom	  distribution.	  In	  female	  mice,	  most	  metastatic	  niches	  
are	  found	  in	  lungs	  and	  ovaries.	  Since	  in	  this	  case,	  the	  goal	  was	  to	  isolate	  macrophages	  in	  contact	  with	  
established	  metastases,	  we	  indeed	  took	  the	  lungs	  and	  ovaries.	  
	   Morphologically,	  the	  extracted	  WT	  lungs	  showed	  only	  two	  apparent	  metastases,	  the	  KO	  one	  
did	  not	  present	  any.	   In	  ovaries,	   it	  was	  striking	  to	  see	  the	  difference	  between	  WT	  and	  KO	  mice:	  WT	  
ovaries	  were	  around	  10	  fold	  bigger	  than	  normal	  ovaries	  and	  KO	  ones	  were	  bigger	  as	  well,	  but	   to	  a	  
lesser	  extend.	  	  
	   The	  extracted	  organs	  were	  prepared	  as	  explained	  in	  the	  methods	  part	  to	  specifically	   isolate	  
macrophages.	   A	   FACS	   analysis	  made	   on	   pre-­‐	   and	   post-­‐sorted	   populations	   allowed	   saying	   that	   the	  
isolation	  was	  efficient:	  	  
-­‐ In	   lungs,	  the	  population	  of	  CD45+cells,	  corresponding	  to	   immune	  cells,	  was	  more	   important:	  
permissiveness	  of	  this	  organ	  is	  higher	  since	  metastases	  are	  more	  widely	  dispersed	  all	  around	  
the	  organ,	  so	  that	  infiltration	  by	  immune	  cells	  is	  easier.	  Moreover,	  population	  of	  CD11+	  cells	  in	  
the	  negative	  fraction	  after	  sorting	  was	  around	  4%	  of	  immune	  cells	  and	  the	  positive	  fraction	  of	  
90%.	  
-­‐ In	  ovaries,	  we	  could	  expect	  infiltration	  to	  be	  more	  difficult	  for	  immune	  cells:	  detected	  CD45+	  
cells	  were	  less	  represented	  than	  in	   lungs.	  The	  CD11+cells	  population	  was	  indeed	  lower,	  with	  
only	  3.15%	  of	   total	   immune	  cells	  detected	  by	  FACS.	   	   In	   the	  negative	   fraction,	  only	  0.04%	  of	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Interestingly,	  only	  57%	  of	  lung	  cells	  were	  CD45+	  (common	  leukocyte	  antigen)	  in	  the	  NALP3	  KO	  
mouse,	  versus	  78%	  for	  the	  WT	  lung:	  the	  lack	  of	  IL-­‐1β	  secretion	  in	  NALP3	  KO	  mice	  leads	  to	  a	  lower	  
accumulation	  of	  immune	  cells	  upon	  B16-­‐F10	  metastases	  stimulation.	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Graph	  13	   :	   FACS	   analyses	  of	   	  A)	   	   sorted	   immune	   cells	   (red	   and	  pink)	   in	   lungs	   	   B)	  
sorted	  monocytes	  (red)	  in	  lungs	  	  C)	  monocyte	  population	  in	  the	  negative	  fraction	  of	  
lungs	  (red)	  D)	  monocyte	  population	  in	  the	  positive	  fraction	  	  
	   	  	  
	   After	   isolation	   of	   macrophage	   population,	   we	   extracted	   totRNA	   from	   these	   samples	   as	  
described	  before.	  This	  material	  was	  then	  sent	  to	  the	  DAFL	  for	  further	  micro-­‐arrays	  gene	  expression	  
analyses.	  The	  goal	   is	   to	   figure	  out	   the	  differences	   in	  gene	  expression	  profiles	  between	  WT	  and	  KO	  
macrophages	  being	  in	  physical	  contact	  with	  tumor	  cells,	  at	  metastatic	  niches.	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5.	  DISSCUTION	  &	  PERSPECTIVES	  	  
	  
	   The	  present	  study	  tried	  to	  figure	  out	  significant	  aspects	  of	  metastatic	  spread	  regarding	  two	  
different	   cell	   lines	   with	   paradoxical	   behavior.	   The	   NALP3	   mouse	   model	   helped	   us	   assessing	   the	  
importance	   of	   the	   IL-­‐1β	   cascade	   in	   the	   promotion	   of	   metastases	   by	   playing	   with	   inflammatory	  
context.	   Collected	   results	   pointed	   out	   that	   genetic	   and	   epigenetic	   modifications	   are	   exploited	   by	  
cancer	  cells	  for	  their	  malignant	  evolution	  and	  spread.	  Moreover,	  we	  noticed	  opportunistic	  adaptation	  
to	  host	  physiology,	  resulting	  in	  different	  patterns	  of	  gene	  expression	  profiles.	  	  
	  
	  
	   First	   of	   all,	   the	   simulation	   of	   cancer	   microenvironment	   we	   could	   re-­‐create	   by	   the	   use	   of	  
inserts	  was	  conclusive	  to	  demonstrate	  influence	  and	  cross-­‐talk	  that	  take	  place	  between	  tumor	  cells	  
and	   macrophages.	   Regarding	   tumor	   cells,	   this	   experiment	   was	   also	   helpful	   in	   distinguishing	   the	  
opposite	  behavior	  the	  two	  selected	  cell	  lines.	  LLC,	  more	  independent	  of	  immune	  activation,	  secretes	  
a	  lot	  of	  cytokines,	  playing	  themselves	  the	  role	  of	  activating	  cell.	  These	  cells	  moreover	  express	  a	  basal	  
level	   of	   mIL-­‐1R1	   that	   is	   high	   compared	   to	   B16-­‐F10,	   another	   point	   that	   could	   account	   for	   their	  
independency.	   On	   the	   other	   hand,	   B16-­‐F10	   cells	   are	   more	   dependent	   on	   an	   activated	  
microenvironment:	   their	   cytokine	   secretion	   is	   decreased	   upon	   contact	   with	   immune	   cells	   in	   the	  
experiment.	   The	   two	   opposite	   behavior	   observed	   are	   render	   investigations	   more	   relevant	   in	   the	  
context	   of	   NALP3,	   since	   the	   latter	   plays	   an	   important	   role	   in	   the	   release	   of	   IL-­‐1β	   in	  
microenvironment.	  
	  
	   Gene	  expression	  analyses	   for	  macrophages	  of	  different	  NALP3	  background	  were	   instructive	  
in	   terms	   of	   adaptation	   mechanisms:	   cross-­‐talks	   with	   tumor	   cells	   induced	   more	   receptor	   to	   be	  
expressed,	   with	   a	   concomitant	   up-­‐regulation	   of	   the	   NALP3	   gene	   itself.	   These	   facts	   reflect	   the	  
influence	  tumor	  cells	  can	  induce	  in	  their	  microenvironment,	  rendering	  the	  latter	  a	  major	  contributor	  
of	  metastatic	  progression.	  The	  protein	  level	  analyses	  confirmed	  these	  influences.	  
	  
	  
	   These	  preliminary	  experiments	  led	  us	  to	  consider	  gene	  expression	  studies	  with	  a	  plethora	  of	  
different	  gene.	  To	  calk	  real	  metastatic	  events,	  we	  performed	  in	  vivo	  experiments	  by	  the	  injection	  of	  
cells	   in	  both	  NALP3	  backgrounds.	  Laser	  microdissection	  allowed	  specific	  metastatic	  niches	   isolation	  
and	   the	   extracted	   samples	   allowed	   performing	   micro-­‐arrays	   to	   figure	   out	   the	   gene	   expression	  
profiles	   of	   B16-­‐F10	   metastasizing	   in	   both	   backgrounds.	   	   The	   results	   that	   will	   come	   out	   from	   this	  
experiments	   will	   certainly	   highlight	   different	   signaling	   cascades	   that	   are	   involved,	   opening	   new	  
insights	  to	  further	  investigate	  this	  mouse	  model	  and	  its	  relevance.	  	  
	  
Concerning	   the	   study	   of	   microenvironment	   gene	   expression,	   we	   decided	   not	   to	   use	   laser	  
assisted	  microdissection,	  since	  different	  cells	  would	  be	  extracted	  in	  that	  way.	  The	  extraction	  of	  fresh	  
macrophages	  upon	  injection	  of	  B16-­‐F10	  was	  therefore	  performed,	  using	  organs	  strongly	  invaded	  by	  
tumor	   cells.	  We	  expect	   these	  macrophages	   to	   be	   associated	   and	   in	   direct	   contact	  with	  metastatic	  
niches.	  The	  next	  step	  of	  this	  experiment	  that	  is	  now	  set	  up	  will	  be	  to	  launch	  microarrays	  in	  order	  to	  
figure	  out	  adaptation	  mechanisms	  involved.	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Knowing	  gene	  expression	  profiles	   from	  both	   sides	  will	   be	  more	   instructive,	   allowing	  better	  
appreciating	   and	   understanding	   of	   occurring	   crosstalk,	   especially	   at	   the	   level	   of	   cytokines	   and	  
chemokines	  secretion	  pathways.	  	  
	  
	  
	   The	  basic	   investigations	  at	  the	   level	  of	   IL-­‐1R1	  were	  also	  preliminary:	  we	  could	  demonstrate	  
that	  modification	  ,	  either	  up-­‐	  or	  down-­‐regulations,	  did	  not	  change	  global	  phenotypical	  traits	  such	  as	  
proliferative	  and	  migratory	  capacities.	  However,	  as	  explained	  before,	  it	  was	  standard	  and	  preliminary	  
in	  vitro	  tests	  to	  perform	  before	  investigating	  in	  more	  details	  the	  role	  of	  this	  key	  immune	  receptor.	  	  
	  
	   The	   in	   vivo	   experiments	   figured	   out	   that	   overexpression	   of	   this	   receptor	   did	   not	   induce	   a	  
stronger	  metastatic	  spread	  of	  tumor	  cells.	  We	  could	  explain	  that	  by	  the	  fact	  that	  this	  receptor,	  beside	  
its	  implication	  and	  importance	  in	  immune	  cells,	  shares	  many	  downstream	  signaling	  molecules	  with	  a	  
myriad	   of	   other	   key	   signaling	   cascades.	   The	   next	   steps	   here	  would	   be	   to	   investigate	   this	   complex	  
signaling	   pathway	   and	   try	   to	   figure	   out	   which	   one	   represents	   the	   real	   limiting	   factor.	   Since	   IL-­‐1β	  
cascade	   mainly	   signals	   through	   NF-­‐κB,	   we	   also	   want	   to	   investigate	   more	   deeply	   at	   this	   level.	  	  
Moreover,	  NF-­‐κB	  signaling	  could	  influence	  NALP3	  background	  in	  several	  ways	  that	  are	  not	  described	  
yet.	  However,	  the	  work	  on	  IL-­‐1R1	  to	  diminish	  propagation	  of	  tumor	  cells	  could	  represent	  a	  real	  and	  
targetable	  appealing	  new	  key	  molecule,	  at	  least	  for	  a	  given	  set	  of	  tumor	  cells.	  	  
	  
	  
These	   exciting	   new	   insights	   will	   hopefully	   be	   further	   investigated	   in	   the	   next	  months.	  We	  
reckon	   that	   the	   NALP3	   mouse	   model	   will	   be	   very	   instructive	   to	   figure	   out	   complex	   events	   of	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